Next Article in Journal
Factors Influencing HPV Vaccine Intentions in Malaysian Men Who Have Sex with Men: A Cross-Sectional Study in Malaysia
Previous Article in Journal
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Plants and Their Derivatives as Promising Therapeutics for Sustainable Control of Honeybee (Apis mellifera) Pathogens

1
Department of Health Sciences, University of Catanzaro Magna Græcia, 88100 Catanzaro, Italy
2
Mediterranean Ethnobotanical Conservatory, Sersale (CZ), 88054 Catanzaro, Italy
3
National Ethnobotanical Conservatory, Castelluccio Superiore, 85040 Potenza, Italy
4
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, 87036 Cosenza, Italy
5
Department of Health Sciences, Institute of Research for Food Safety & Health (IRC-FISH), University of Catanzaro Magna Græcia, 88100 Catanzaro, Italy
6
Nutramed S.c.a.r.l., Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
*
Author to whom correspondence should be addressed.
Pathogens 2023, 12(10), 1260; https://doi.org/10.3390/pathogens12101260
Submission received: 12 September 2023 / Revised: 8 October 2023 / Accepted: 18 October 2023 / Published: 19 October 2023

Abstract

:
The most important pollinator for agricultural crops is the Western honeybee (Apis mellifera). During the winter and summer seasons, diseases and stresses of various kinds endanger honeybee numbers and production, resulting in expenses for beekeepers and detrimental effects on agriculture and ecosystems. Researchers are continually in search of therapies for honeybees using the resources of microbiology, molecular biology, and chemistry to combat diseases and improve the overall health of these important pollinating insects. Among the most investigated and most promising solutions are medicinal plants and their derivatives. The health of animals and their ability to fight disease can be supported by natural products (NPs) derived from living organisms such as plants and microbes. NPs contain substances that can reduce the effects of diseases by promoting immunity or directly suppressing pathogens, and parasites. This literature review summarises the advances that the scientific community has achieved over the years regarding veterinary treatments in beekeeping through the use of NPs. Their impact on the prevention and control of honeybee diseases is investigated both in trials that have been conducted in the laboratory and field studies.

1. Introduction

Since the honeybee (Apis mellifera), the most significant pollinator under commercial management, provides more than USD 200 billion in annual services to agriculture, honeybee diseases are a significant source of economic loss [1,2,3]. Although honeybees have developed effective defence mechanisms to counter infection at both the individual and societal levels, a variety of diseases and parasites can still be encountered in their colonies [4,5,6]. Infectious agents are known to spread more rapidly in overcrowded conditions. A large population of individuals within each colony seems to make honeybees particularly susceptible to pests and diseases. Some of the most significant infections affecting honeybees are the fungi Ascosphaera apis and the bacteria Paenibacillus larvae and Nosema spp (Figure 1). Mites also pose threats to A. mellifera [7,8,9]. Research has shown the crucial role of Varroa destructor (V. destructor) in the spread of viruses, which are responsible for significant losses of honeybee colonies in Europe and the United States [10,11,12]. Due to the considerable danger of contaminating apiary products, the use of veterinary chemical medications in the treatment and prevention of honeybees diseases has significantly decreased recently [13]. In order to effectively avoid the spread of diseases in honeybee colonies, it thus appears justified to pay closer attention to the value of preventive therapies and the search for new sustainable and safer remedies. For a very long time, herbal remedies have been utilised successfully in the treatment of human diseases [14,15]. New applications for their usage in human and veterinary medicine are simultaneously being found [16,17,18,19,20]. The usage of the majority of natural compounds (pyrethrum, neem oil, rotenone, nicotine) as insecticides dates back many years [21,22]. They typically decay faster in sunshine, air, and moisture than synthetic products, which is a major benefit [23]. They also do not bioaccumulate in the environment. They are often more selective against non-target insects as compared to conventional insecticides [23]. NPs consist of several biologically active substances with pharmacological action while causing fewer side effects than synthetic products [24,25]. One of their observed effects is that they directly or indirectly stimulate processes that increase the resistance and immunity of mammal and invertebrate organisms [26,27]. Several plant species have been identified so far as having immunostimulating characteristics [28,29]. A variety of plants and their derivatives also boost the body’s capacity to fight infections because of their energizing, regenerating, and metabolism-enhancing qualities [30,31,32]. In addition, some plants exhibit direct effects on pathogens by reducing their multiplication and consequently decreasing the infectious load [19,33,34]. Research on the potential application of plants and their components in beekeeping has so far been mostly directed at finding ways to utilise NPs to combat certain diseases by making use of their antibacterial, antifungal, or antiviral capabilities. The efficacy of herbal-derived medicines in treating European foulbrood (EFB), American foulbrood (AFB), and chalkbrood disease has been evaluated in several experiments. For example, essential oils (EOs) have been shown to be particularly effective against Paenbacillus larvae [35,36]. Several EOs, such as those obtained from oregano, fennel, mint, thyme, salvia, and pine oils, have all been used to try to manage the V. destructor pest [37,38,39]. This literature review came about with the aim of summarising the progress achieved in combating the main hive pathogens by means of NPs. Particular emphasis was given to the activity of EOs and their general mechanisms of action, concerning which there are a large number of scientific articles.

2. Mechanisms of Action

2.1. Antibacterial Activity

Given the many chemical constituents found in EOs, it is rare to be able to pinpoint a single mode of action against bacterial cells but rather a variety of targets against which these chemicals operate are commonly seen. Their hydrophobicity, which enables them to break the bonds between the lipids of the membrane of bacterial cells and mitochondria, is a crucial property of EOs and their compounds [40,41]. This property alters the structures of cell membranes that become more permeable as a consequence. The activity results in ions and other cellular components being lost. The cell can withstand some of these losses but often results in cell death [42,43]. According to Lambert et al., 2001, Gram-positive bacteria are often more vulnerable to the effects of Eos than Gram-negative bacteria [44]. The variations in cellular wall construction account for this finding. Gram-positive bacteria have thicker (about 20 nm) cell walls but simpler structures. They do not include lipids and are covered in a thick coating of peptidoglycan that is interspersed with linear chains of teichoic acid. Gram-negative bacteria have thinner cell membranes but more complex structures. They are made up of numerous peptidoglycan layers that are coated in a layer of lipoproteins and lipopolysaccharides that also include amino acids but lack teichoic acid [45]. The outer envelope is what increases the Gram-negative bacteria’s resistance to the effects of numerous chemicals, including those of plant extracts [46]. The crystal violet test and the measurement of the released UV-absorbing material assays may both be used to identify changes in membrane permeability [47,48]. The crystal violet test is based on the observation that when the cell membrane is damaged, the chemical is readily able to penetrate it. The idea behind UV-absorbing material tests is that Eos may damage cell membranes, allowing the cell’s contents to seep out and be detected on the UV spectrum. According to Denyer and Hugo, 1991, phenolic compounds like thymol, carvacrol, and geraniol have the most potent antibacterial effects [49,50]. These compounds work by altering the cytoplasmic membrane, disrupting the proton-motor force and electron flux, blocking active transport, and coagulating cell contents. The precise mechanism of the action and antibacterial activity of Eos are influenced by the chemical composition of their constituent parts [51]. Knobloch et al., 1986, and Dorman and Deans, 2000, have both proven the significance of a hydroxyl (OH) group in phenolic compounds like carvacrol and thymol [41,51]. In fact, the degree of antibacterial activity of thymol and carvacrol, both of which have the hydroxyl group at distinct positions, has been revealed to be very comparable for bacteria like Bacillus cereus, Staphylococcus aureus, and Pseudomonas aeruginosa [44,52]. Carvacrol and thymol, however, have been shown to operate against Gram-positive and Gram-negative bacteria differently in other experiments [51]. The ineffectiveness of menthol, which lacks the phenolic ring, highlights the significance of its existence. Instead, the inclusion of the acetate group seems to improve the antibacterial activity; in fact, geranyl acetate appears to be more effective than geraniol against various species of Gram-positive and Gram-negative bacteria [51]. In addition, it has been possible to highlight that the biological activity of the nonphenolic components that make up the EOs may differ depending on the type of functional group that is present; for instance, the alkenyl group (C = C) is more efficient than the alkyl group (C-C), making limonene more active than p-cynene [51]. According to Knobloch et al., 1989, the constituents of EOs seem to have the ability to interact with the proteins that make up the cytoplasmic membrane [40]. It is common knowledge that lipid molecules surround membrane-bound enzymes like ATPase, and two potential mechanisms of action have been proposed: first, when a cyclic hydrocarbon acts on these molecules, lipophilic molecules may accumulate in the membrane’s lipid bilayer, changing the way proteins and lipids bind to one another; second, a direct change within the lipophilic part and the hydrophobic part of the protein may occur [50,53]. Therefore, the various EOs mechanisms of action are diverse and distinct from one another, resulting in a sum of every mechanism of action of their individual component. Because of this high level of variability, it is believed that microorganisms cannot develop resistance to these substances [6,42]. However, variations in composition among different Eos, even from the same kind of plant, may pose a problem as their antibacterial actions could vary. For the evaluation of the activity, it is necessary to remark that there are currently no accepted standards for classifying the antibacterial activity of NPs. According to Holetz et al., 2002, the antibacterial activity of vegetal extracts was excellent if the minimum inhibitory concentration (MIC) was less than 100 µg mL−1; moderate if it was between 100 and 500 µg mL−1; weak if it was between 500 and 1000 µg mL−1; and inactive if it was above 1000 µg mL−1 [54].

2.2. Antifungal Activity

EOs have the potential to disrupt, modify, or impede the production of cell walls in fungus. Anise oil’s main ingredient, trans-anethole, showed antifungal action against the filamentous fungus Mucor mucedo IFO 7684, along with morphological alterations to the hyphae, such as enlarged tips. In permeabilised hyphae, anethole dose-dependently reduced chitin synthase (CHS) activity [55]. Aspergillus niger cannot develop when exposed to the EO from Citrus sinensis epicarp, which has a high percentage of limonene (84.2%). It also causes permanent negative morphological changes, including the depletion of cytoplasm in the hyphae of fungal organisms and the budding of hyphal tips [56]. The main chemical in the EO of black cumin seed, thymoquinone, caused significant fungal cell wall and cell membrane damage, according to Iscan et al., 2016 [57]. A large proportion of phenolic monoterpenes, including thymol and carvacrol, was present in certain EOs, while others contained mostly non-phenolic terpenes. In EOs with potent efficacy against mould, the phenylpropanoid eugenol was often found. The bicyclic monoterpenes camphor and pinene, which are non-phenolic, have shown notable antifungal effects in certain instances. High thymol, carvacrol, cymene, linalool, or α-pinene concentration has been seen in EOs with potent action against yeasts. Surprisingly, a number of EOs with inhibitory activities against yeasts were discovered in the Lamiaceae family of genera, including Thymus spp., Origanum spp., Salvia Rosmarinus, Ocimum sanctum, and Zataria multiflora [58,59]. Citrus sinensis EO was found to be abundant in limonene (84.2%). It displays a strong antifungal effect against Aspergillus niger, causing the rupture of the mycelial walls [56].
Furthermore, it has been shown that EOs may stop spores from growing. Sant’Anna et al., 2009, found that Achillea millefolium EO, containing 42.2% chamazulene, has genotoxic effects on fungal cells and inhibited spore growth [60].
By preventing the activity of mitochondrial dehydrogenases involved in ATP generation, such as lactate dehydrogenase, malate dehydrogenase, and succinate dehydrogenase, some EOs may impact the efficiency of the mitochondria. According to Chen et al.’s research, 2013, the EO of Anethum graveolens may serve as an antifungal agent in addition to disrupting the citric acid cycle and preventing the generation of ATP in C. albicans mitochondria [61].
Another mechanism by which EOs act is by interfering with the membranous pump flows of fungi. The enormous transmembrane electrochemical proton gradient required for food intake is supported by the fungal plasma membrane H+-ATPase, which is crucial to the fungal cell’s function. In addition to controlling internal pH and fungus cell development, the H+-ATPase also affects dimorphism, nutrient absorption, and medium acidification, which all contribute to fungus pathogenicity [62,63]. Cell death and intracellular acidification result from H+-ATPase inhibition. This is the target of eugenol and thymol, which are fungicidal agents even against azole-resistant fungi [64]. The main chemical components of thyme EO, thymol and carvacrol, combined with the azole antimycotic fluconazole showed an antifungal effect that was synergistic. This was accomplished by preventing the overexpression of the efflux-pump genes CDR1 and MDR1 in Candida albicans [62].

2.3. Antiviral Activity

Viral attachment, penetration, and entry into the host cell result in the replication of genetic material and the production of additional virions. Viral infectivity is inhibited by adverse action on associated targets engaged in the infection phase. The greatest options for clinically effective antiviral drugs are those that target certain viral biosynthetic stages. These antiviral formulations should stop the propagation of viruses, work at low concentrations, have no effect on the functioning of the host cell, and eventually heal infected cells. The main mechanism of antiviral effects of EOs is the capsid disintegration, which prevents the virus from infecting host cells [65]. Being lipophilic in nature, EOs can penetrate viral membranes, easily leading to membrane disintegration. EOs also inhibit the haemagglutinin of certain viruses; this membrane protein allows the virus to enter the host cell [66]. Many EOs and their components can inhibit the late stages of the viral life cycle by targeting the redox signalling pathway [67]. EOs of Thymus vulgaris, Cymbopogon citratus and Salvia Rosmarinus have been found to destabilise the Tat/TAR-RNA complex of HIV-1 virus, an essential complex for HIV-1 replication [68]. EOs have been tested against a large number of pathogenic viruses, such as influenza and other respiratory viral diseases [66,69]. According to studies, the EOs of cinnamon, bergamot, lemongrass, thyme, and lavender have strong antiviral activity against influenza A virus [70]. Eos of Citrus reshni leaves has been shown to have beneficial effects against the H5N1 virus [71]. In Vero cells, it has been shown that the EO of the Lippia species at a concentration of 11.1 µg/mL causes the 100% inhibition of the yellow fever virus [72]. Through in vitro and in vivo tests, it has been shown that oleoresins and EOs may have antiviral effects against the infectious bronchitis virus caused by the avian coronavirus [73]. This evidence supports the possible use of EOs as antiviral agents in beekeeping.

2.4. Acaricidal Activity

Some fixed (solvent) extracts from plants have been investigated as potential varroacidal sources (as mixtures or isolated compounds) [74,75,76,77]. However, EOs are among the natural substances that have been most thoroughly investigated for this use. As a statement of reality, searching for EOs with anti-varroa activity represents a logical strategy as EOs show several properties against arthropods, such as repellence [78], dissuasion [79], and toxic effects when fumigated, externally applied, or eaten [80,81]. According to Isman, 2000, toxicity may result in cuticle disruption, moulting, and respiration suppression, as well as a decrease in growth and fecundity rates [22]. These diverse forms of pharmacological action may be caused, at the molecular level, by the inhibition of acetylcholinesterase. However, this mechanism was demonstrated only in vitro for a small subset of monoterpenes [82]. Investigations into the mechanisms of action of monoterpenoids suggest that a mode of action for EOs is the inhibition of acetylcholinesterase enzyme activity. Thymus praecox subsp. caucasicus, Cyclotrichium niveum, Santolina chamaecyparissus, Ormenis multicaulis, Echinacea purpurea, Salvia chionantha, Anethum graveolens, and Salvia lavendulaefolia have all been shown to inhibit AChE [83,84,85,86,87]. Multiple aspects of this inhibitory activity were assessed. Among 73 substances, 48 that showed anti-AChE activity were assessed. When 28 compounds were tested on insect AChE, 23 of them inhibited the enzyme. 1,8-cineole, cis-ocimene, niloticin, limonene, menthol, α-pinene, β-phellandrene, and carvacrol were the most efficient [86,87,88,89,90]. The bulk of the EO components exhibited anti-AChE activity at mM doses. Only one investigation demonstrated that the carvacrol component of EOs may inhibit AChE in a µM concentration [91].
The majority of studies have linked the biological activity of EOs to the prevention of octopamine (OA)-binding to their receptors [92,93,94], as there are parallels between OA activity and exposure to monoterpenoids as well as evidence that OA antagonists block the effects of monoterpenes on insect neuronal responses [92,95]. The final effect is a decrease in the concentration of cAMP. This mechanism has the benefit that OA is not employed by vertebrates as often as it is by arthropods [96], allowing selection between these species to be at least theoretically possible when searching for biopesticides to be used against arthropods. Numerous EO components have been shown to have pharmacological effects and affect insects’ octopaminergic systems [97]. For example, geraniol and citral greatly reduced cAMP levels. The same EOs decreased [3H] OA’s affinity for receptors. Another mechanism by which EOs function is via GABA-gated chloride channels [98]. Since insect GABArs differ from human GABArs in both structure and pharmacology; these are very intriguing targets for the creation of novel pesticides. Thymol, menthol, and other substances increase the Cl- current brought on by the GABA neurotransmitter. The GABAArs Cl- current is unaffected by several EO elements, including camphor, carvone, menthone, linalool, and α-terpineol. The chemical makeup of the EO components affects how they interact with GABA receptors. The ability of various EO stereoisomers to modulate GABA receptors varies; (+)-menthol and (+)-borneol are more potent than (−)-menthol and (−)-borneol. Likewise, the functional group is also essential. The GABAArs are more modulated by alcohols like thymol, menthol, and borneol than by ketones like linalool and α-terpineol.

3. Control of Honeybee Pathogens and Parasites via NPs

The hive superorganism has to deal with numerous pests and diseases. Some of them are minor and the diseases they produce can be managed even after they have spread. They will therefore not threaten the survival of the colony. Others can lead to colony collapse if they go unnoticed. In the following subsections, we will take stock of the achievements of the scientific community in controlling important bacterial, fungal, viral, and parasitic bee diseases using NPs.

3.1. Paenibacillus larvae and Melissococcus plutonius

AFB is the most serious and pervasive infectious disease of honeybees and affects the brood. It is present in practically every nation on every continent, with the exception of a few tropical regions in Africa and Asia [99,100]. For this reason, it causes huge financial losses in beekeeping worldwide [101]. A Gram-positive, facultative anaerobic, sporigenic bacteria known as Paenibacillus larvae—previously known as Bacillus larvae—is the culprit [99]. The bacteria originate from the spores that, in a favourable environment and under ideal circumstances, may germinate and multiply in approximately 30 min [102]. The spores are the bacterium’s resistant form because they are covered in a very durable membrane that shields them from environmental stresses. The digestive system of immature honeybee larvae provides the semi-aerobic environment that spores need to germinate. Therefore, after being consumed with food, the spores enter the lumen of the midgut where they germinate. Here, the vegetative bacterial forms begin to grow. Massive bacterial growth occurs at the expense of the food consumed by the larva. It is only later that the bacteria breach the peritrophic membrane, assault the intestinal epithelium, move into the haemocele, and grow in the haemolymph of the larva, resulting in septicaemia that leads to larval death [103,104].
AFB has no effective treatments at this time. This disease has been treated with antibiotics with predominantly bacteriostatic activity, such as oxytetracycline hydrochloride [105,106]. If used inaccurately, they mask the symptoms of the disease but not its spread. Furthermore, drug resistance phenomena could occur. For these reasons and the possibility of contaminating hive products, several countries prohibit the use of antibiotics in the treatment and prevention of AFB [13]. It is also important to remember that unlike the vegetative form, the spore-forming form cannot be affected by antibiotics or chemotherapeutics. The best course of action in situations of overt sickness is still to destroy infected colonies and combs by burning them. AFB prevention and control techniques often involve monitoring for early diagnosis, isolating apiaries with instances of AFB, expanding healthy colonies using hygienic queens, and practicing the shaking technique when symptoms are already present. As far as European foulbrood (EFB) disease is concerned, it should be said that it is caused by the bacterium Melissococcus plutonius (M. plutonius), which is often associated with other bacterial agents, including Streptococcus faecalis, Achromobacter eurydice, Paenibacillus alvei, and Bacillus laterosporus [107,108]. Depending on the type of bacteria associated with M. plutonius, European foulbrood may manifest itself in the affected family with a different symptomatology (e.g., the presence/absence of particular odours). M. plutonius is a germ that, although asporigenic, is fairly resistant to environmental adversity: it can resist desiccation for up to a year; it can remain viable in pollen for several months. Similarly to AFB, within the hive, the disease is spread orally by nurse honeybees, which unwittingly smear themselves with germs in an attempt to clean the brood cells of dead EFB larvae and then, when they feed the brood, they infect them [108,109]. From hive to hive or from apiary to apiary, the disease can be spread either through honeybee action (especially when looting takes place) or by mistakes made by the beekeeper (using infected honey to feed healthy families, moving sick families during nomadism, trading in infected beekeeping material, using contaminated equipment, moving combs from one hive to another, etc.) [108,110,111]. Although the disease can occur at any time of year, it is more frequent in spring/summer, when the brood is at its peak. This observation led to the assumption that the disease could be favored by an imbalance between the number of larvae and the number of nurse honeybees. Furthermore, EFB appears to be more frequent in cold and rainy springs, when there may be food shortages, particularly of protein, as the brood lacks pollen [112]. After infection, the larvae reach death within the first four days of life, (regardless of whether the larvae are worker, drone, or queen larvae). The death of the larvae therefore takes place in an open cell, and this is one of the characteristics that allows EFB to be differentiated from AFB [110,113]. Prophylaxis involves renewing combs every 2–3 years, eliminating queens predisposed to the disease, carrying out artificial swarming correctly, and trying to avoid numerical imbalances between adult honeybees and brood. As with AFB, in conjunction with other good beekeeping practices, the shook swarm procedure may prove useful in suppressing infection [114,115]. In this particular context, the creation of innovative and efficient techniques for the management and prevention of AFB and EFB disease is critical. These techniques may take into account proof of bacterial resistance phenomena, adhere to tight EU requirements, and reflect current green consumption patterns [116,117]. Alternative methods of preventing and treating AFB and EFB are now being researched, with a focus on EOs, propolis and probiotics [118,119]. The capacity of certain EOs to stop P. larvae from growing was examined in a number of experiments that are presented below. In the studies of Alippi et al., 1996 and 2001, the antimicrobial effects of EOs on Paenibacillus larvae were investigated using summer savory (Satureja hortensis), lavender (Lavandula hybrida), eucalyptus (Eucalyptus globulus), lemongrass (Cymbopogon citratus), peppermint (Mentha piperita), oregano (Origanum vulgare), rosemary (Salvia Rosmarinus), and thyme (Thymus vulgaris). The strongest action against P. larvae was found in EO of lemongrass, and thyme [35,120]. Similar positive conclusions were reached by Fuselli et al., 2005 and 2006, verifying that Andean thyme (Acantholippia seriphioides) had a marked antibacterial effect [36,121]. This EO demonstrated the highest inhibitory activity against the agent responsible for AFB. Kloucek et al., 2008, showed that, under the tested concentrations of 1–256 nL/mL, the EO of Armoracia rusticana (MIC 16 nl/mL) had the most pronounced impact on Paenibacillus larvae, followed by oils of Thymus vulgaris (MIC 64 nl/mL), Mentha spicata var. crispa (MIC 64 nl/mL), and Satureja hortensis (MIC 128 nl/mL), which, however, showed moderate efficacy [122]. In 2009, Gende et al. demonstrated that the EO of cinnamon (Cinnamomum zeylanicum) possesses AFB disease control activity similar to that of oxytetracycline [123]. Both a lab test and a field experiment were conducted to determine whether the EO of cinnamon had anti-Paenibacillus larvae activity. The tube dilution technique was used to estimate the MICs (minimum inhibitory concentrations) against P. larvae. The apiary study was conducted employing three groups of five hives each. Three doses of oxytracycline-HCl (0.4 g each) were given to the first group, two doses of cinnamon oil (1000 g/mL each) were given to the second group, and the third group was kept untreated as a control. Treatment effectiveness was deducted, observing a 360 cm2 (18 × 20 cm) brood surface and the number of infected brood cells on both sides of a central comb. The C. zeylanicum MICs for the antibiotic and EO were 50 µg/mL and 3.125 µg/mL, respectively, for the Mar del Plata AFB strain. Control beehives showed more infected cells than treated beehives. The antibiotics and the cinnamon EO, which were both tested, were thus successful in controlling AFB [123]. In 2012, Cecotti et al. demonstrated cinnamon-like efficacy for the volatile fraction of Polygonum bistorta. They also added an additional important piece of information, namely that plant activity varied with phenological stage [124]. Melissococcus plutonius and Paenibacillus larvae were used as test subjects for the EO. The inhibition area in the tests against Paenibacillus larvae ranged from 7.5 to 8.5 mm for the vegetative phase, from 7.5 to 13.0 mm for the blooming phase, and from 24.0 to 24.5 mm for the fruiting phase, demonstrating a noticeably rising level of activity over time. In the test against the three strains of Melissococcus plutonius, absolute inhibition levels were less prominent, but the results revealed a similar upward trend. Data from the bark and leaves of C. zeylanicumin, one of the botanical species that is most effective against the AFB, were compared with those from the isolates in order to provide a better benchmark for the amount of bioactivity of the isolates. P. bistorta oils demonstrated antibacterial activity against all bacterial strains with areas of inhibition that varied from 2.5 mm toward M. plutonius CRA-API08/1 to 24.5 mm toward P. larvae CRA-API10/8, showing inhibition values similar to those of C. zeylanicum in the flowering phases. It is important to note that P. bistorta in the fruiting phase showed inhibition values similar to those displayed by oxytetracyclin against P. larvae (36.0–39.0 mm inhibition area). While EOs from rosemary, and fennel exhibited minimal or poor antibacterial action, Kuzysinova et al., 2014, identified the maximum suppression of P. larvae using EOs of oregano, thyme, and clove [125]. In a more recent study, Pellegrini et al., 2017, examined the EOs of Aloysia polystachya, Acantholippia seriphioides, Schinus molle, Solidago chilensis, Lippia turbinata, Minthostachys mollis, Buddleja globosa, and Baccharis latifolia for their antibacterial activity [126]. At 260 nm, EO-induced releases of UV-absorbing P. larvae cell material were detected. With the exception of B. latifolia EO, all EOs exhibited antibacterial action against P. larvae and damaged the cell wall and cytoplasmic membrane of P. larvae, causing the leaking of cytoplasmic components [126]. Using the agar diffusion method, the antibacterial effects of several extracts from Flourensia riparia, Flourensia fiebrigii, and Flourensia tortuosa against P. larvae were also studied. Using this method, the extracts of chloroform, ethyl ether, and hexane at varying concentrations (100 to 50,000 µg mL−1) exhibited an inhibitory effect [127]. One hundred micrograms of dry extracts isolated from the inflorescences of different Hypericum species showed similar antibacterial action against P. larvae. The diameters of the inhibitory halos were similar when applying as little as 25 µg of these extracts when compared to 1000 µg of lactic acid (positive control) [128]. The antibacterial effects of Vitex trifolia (Barbaka) and Azadirachta indica (Neem) crude aqueous extracts (20, 40, and 60 mg mL−1 disk−1) against P. larvae were dose-dependent, with the larger inhibition zones being associated with the Barbaka plant [129]. According to Gonzaléz and Marioli, 2010, water extracts of Achyrocline satureioides, Chenopodium ambrosioide, Eucalyptus cinerea, Gnaphalium gaudichaudianum, Lippia turbinata, Marrubium vulgare, Minthostachys verticillata, Origanum vulgare, Thymus vulgaris, and Tagetes minuta prevented the development of P. larvae [130]. The several vegetal species under study varied in their biological activity against the development of P. larvae. E. cinerea, and M. verticillata were those with the greatest activity, having completely prevented the development of any strain of P. larvae. However, the growth of the P. larvae strains was also likewise inhibited by the T. minuta extracts with significant effectiveness (91%). Another plant whose extracts displayed biological action as P. larvae growth inhibitors was A. satureioides (83% effectiveness). The plant species whose extracts were least effective in inhibiting P. larvae growth were O. vulgare and T. vulgaris. While T. vulgaris displayed 50% effectiveness, O. vulgare only displayed 42% [130]. By using the broth microdilution and agar dilution procedures, the hexane extract of A. satureioides’ MIC values were found. These values ranged from 16 to 125 µg mL−1 [131]. In 2014, other extracts of the same plant were analysed using the broth microdilution technique. The hexane, benzene, ethyl ether, and ethyl acetate extracts of A. satureioides produced MIC values of 0.060, 0.131, 0.773, and 6545 µg mL−1, respectively [132]. According to Gende et al., 2008, the broth macrodilution technique yielded a MIC of 5000 µg mL−1 for the ethanolic extract of Melia azedarach [133]. The ethanol–water extracts of Calendula officinalis, Nasturtium officinale, and Laurus nobilis, as well as the crude extracts of Scutia buxifolia and its extracts extracted with dichloromethane, ethyl acetate, and n-butanol fractions were also effective [117,134,135]. A recent study, conducted by Kim et al., 2018, evaluated the antibacterial activity of several molecules isolated from plant seeds and fruits (macelignan, tracheloside, fangchinoline, corosolic acid, loganic acid, emodin-8-O-β-D-glucopyranoside, and dehydrocostus lactone) against the causal agents of European and American foulbrood, P. larvae, and Mellisococcus plutonius [136]. Using the broth microdilution assay, the authors discovered that macelignan possessed the highest degree of anti-P. larvae activity (MIC of 1.56 mg/L after a 24 h incubation and MIC of 3.125 mg/L after a 48 h incubation), followed by corosolic acid, which had similar anti-P. larvae activity (MIC of 3.125 mg/L after a 24 h and 48 h incubation). The anti-M. plutonius activity of macelignan and corosolic acid was similarly quite strong (MIC of 3.125 mg/L at 24 and 48 h of incubation). Loganic acid, tracheloside, fangchinoline, dehydrocostus lactone, emodin-8-O-D-glucopyranoside, kanamycin, and Congo Red demonstrated little or no antibacterial activity, whereas miconazole (1.56~3.125 mg/L) and tetracycline (0.39~1.56 mg/L) proved high antibacterial action against the two strains of bacteria [136]. Hassona confirmed in 2017 that some botanical species have entirely distinct efficacies for AFB and EFB. In both the laboratory and the field, the efficacy of Cinnamomum zeylanicum, Syzygium aromaticum, and Thymus vulgaris against AFB and EFB bacteria was assessed. Thymol had the greatest impact on AFB in the lab, with a total average of 3.37 ± 1.03 cm of growth suppression measured as a circle around the spreading disc for each concentration. Thymol, on the other hand, had the least impact on EFB, with an overall mean of 0.33 ± 0.15 cm. With a total mean of 4.50 ± 2.00 cm and 0.73 ± 0.20 cm on EFB, cloves had the greatest impact. Thymol produced the best brood growth in the apiary, with a 25.8% increase in capped brood over the entire period of treatment. With a total mean of 4.50 ± 2.00 cm and 0.73 ± 0.20 cm on EFB, cloves had the greatest impact. In the apiary, thymol produced the greatest levels of brood growth, with a 25.8% increase in capped brood compared to EFB throughout the course of the treatment period. Cloves, on the other hand, varied the most across each control period, with a 25.3% rise in capped brood across all treatment times [137].
However, the possible adverse effects of EOs on honeybees should not be overlooked when examining the efficacy of these compounds against infections. Kevan et al., 1999, in addition to determining the effectiveness of many EOs in slowing down the development of P. larvae, also provided the LD50 values of the relevant extracts for honeybees [138]. LD50 values for thymol reached 100 ppm, for cinnamon oil 50 ppm, and for clove oil 200 ppm, while peppermint oil was found to be absolutely non-toxic. The LD50 values of thyme, lemongrass, oregano, and basil extracts for adult honeybees were established by Albo et al., 2003 [139]. For the pure essences mentioned above, the LD50 could not be determined, as it yielded a negative curve for the mortality values. The absent or low toxicity to honeybees found in these trials support the use of these EOs/extracts in honeybees.

3.2. Nosema spp.

Adult A. mellifera are susceptible to the infectious disease nosemiasis, which is brought on by the unicellular fungus of the class microsporidia. These are eukaryotic unicellular organisms that reproduce at the cost of the adult honeybees’ gut epithelial cells. Depending on the Nosema species involved, the breed of bee, and the environmental circumstances in which the bees are situated, the disease presents clinically in various ways. There are two main species of Nosema that affect honeybees: N. apis and N. ceranae. The first causes a typical digestive syndrome whose main symptom is diarrhoea. The second has no particular signs, but manifests as a depopulation of the hive [140]. Spores, which are Nosema in its latent condition, are the disease’s main means of transmission. They are surrounded by a thick envelope produced by the cell contained in it; the spore also contains a polar filament, which departs from a sac, known as “polar tube”, that surrounds the peripheral part of the cell [141]. When spores consumed with food make it to an adult bee’s gut, they germinate and produce an amoeboid form with cytoplasm devoid of mitochondria. The filament guarantees adhesion to host cells and acts as an exit duct. The amoeboid form enters the intestinal cells where it starts to grow, develop, and multiply by feeding on the cytoplasm of the cell. In this location, they grow and multiply, producing a large number of cells, each of which will give rise to a spore until the invading cell explodes. The mature spores are then released into the intestine. The spores, which represent the spreading forms of the disease, are poured into the lumen of the intestine and there expelled with the faeces when the intestinal epithelium is regenerated. Upon reaching the outdoor environment, the spores can be ingested by other honeybees, and the biological cycle closes (orofaecal route) [140].
Until a few years ago, Flumidil B was used to control this microsporidian parasite. This antibiotic has been banned in all European Union member states since 2012 and in Italy since 2002. Numerous studies have been carried out on the effects of adding natural derivatives to the diet of honeybees and the prevalence of Nosema spp. cases. In a 2008 study, Maistrello et al. assessed the efficacy of lysozyme, resveratrol, thymol, and vetiver EOs in the treatment of honeybee nosema infection [142]. The experimentally infected groups received candies made with thymol (0.12 mg/g), lysozyme (2.5 mg/g), vetiver (1.2 mg/g), and resveratrol (0.01 mg/g). Spore loads were observed for 25 days. The findings demonstrated that vetiver oil, thymol, resveratrol, and lysozyme had neither harmful nor anti-feedant effects on adult honeybees, since candy consumption was comparable throughout the experimental groups. The study revealed that honeybees given thymol and resveratrol candies had much-reduced infection rates. Furthermore, the resveratrol group survived noticeably longer than honeybees that were fed candy without resveratrol [142]. Thymol had similar impacts on the health of Nosema-infected honeybees, according to Glavinic et al., 2022, who discovered elevated levels of immune-related genes and oxidative stress parameter values as well as a reduction in Nosema spore burden. Thymol may create issues in honeybees not afflicted by Nosema (affecting bee survival, lowering oxidative capacity, and downregulating several immune-related gene expressions), according to the same investigators, who also recommended careful, non-preventive usage of the substance [143]. The EO of Cryptocarya alba was also tested. According to a study by Bravo et al., 2017, C. alba includes 39 different chemicals and, among them, the three main ingredients α-terpineol, eucalyptol, and the monoterpene α-phellandrene. In the study, infected honeybees were divided into three groups: those who received EO C. alba at various dosages (1, 2, 3, and 4 µg/bee); those who received fumagillin syrup (240 µg/bee) as a positive control; and those who were infected and were maintained without any treatment. The findings revealed that the most efficient dosage of 4 µg EO/bee had a spore inhibition rate of 80%, which was comparable to fumagillin. Furthermore, the EO was not harmful to A. mellifera [144]. EOs from a several number of plants, including peppermint (Mentha piperita), lemon balm (Melissa officinalis), summer savory (Satureja hortensis), and coriander (Coriander sativum), have shown anti-nosemosis efficacy and extended the lifespan of diseased honeybees [145]. The product “Supresor 1” (a combination of the abovementioned medicinal herbs extracted using ethyl alcohol) was given to six groups of five honeybees each (experimental modules) at various concentrations of 1 mL, 2 mL, 5 mL, 10 mL, and 50 mL per litre of syrup, along with a positive control (infected non-treated) and two negative control groups (uninfected, treated). Even at a high dosage of 10 mL (2000 mg etheric oil) per litre of syrup, the results showed no toxicity towards honeybees; the ideal dose found was 5 mL per litre of sugar syrup [145]. Plant extracts have also been used to control nosemiasis. As shown by a 77% decrease in spores at a concentration of 100 µg/mL, the ethanolic extracts of Artemisia dubia and Aster scaber exhibit anti-nosemosis properties [146]. Surprisingly, the spore levels were reduced by 76% using aqueous extracts of 1 µg/mL. Aqueous extracts were more active than butanol and ethyl acetate extracts [147]. Six adaptogenic plant extracts, including those from Eleutherococcus senticosus, Garcinia cambogia, Camellia sinensis, and Schisandra chinensis, were examined. The highest anti-nosema action was seen in an extract of the E. senticosus root [148]. A second investigation demonstrated the anti-nosemosis effectiveness of aqueous nest carton extracts made from a jet-black ant nest (Lasius fuliginosus) with no harm to healthy bees. The amount of spores was also reduced by 97.97% by the birch carton extract [149]. The aqueous extract of the Agaricus blazei mushroom proved successful in lowering the amount of N. ceranae spores without creating any negative side effects when used either at the time of infection or as a prophylactic strategy. Most immune-related genes, including abaecin, hymenoptaecin, defensin, and vitellogenin, were expressed more often in the presence or absence of Nosema infection thanks to A. blazei. The extract was well tolerated and acceptable, as seen by the fact that daily dietary intake was similar among the groups [150,151]. In another experiment, in order to feed the infected honeybees, defatted seed meals (DSMs) from Brassica nigra and Eruca sativa were administered for 8 days together with a known number of different glucosinolates. The amounts, which were 2% and 4%, resulted in the suppression of N. ceranae as well as possible nutritional advantages as shown in the length of the honeybees’ lives [152]. Aristotelia chilensis, Ugni molinae, and Gevuina avellana leaves, as well as propolis, were tested for their effects on N. ceranae infection. Propolis and U. molinae extracts, which were successful in treating infected groups, were determined to be adequate [153]. Another investigation on the impact of ethanolic propolis extract on the survival and spore load of worker honeybees infected with N. ceranae revealed that propolis significantly decreased the Nosema spore load in comparison to the control [154]. Furthermore, honeybees with N. ceranae infections lived longer when given propolis extracts and ethanol (a solvent control), but only propolis extract effectively decreased spore burden [155]. The mortality, infectivity, and N. ceranae infection rates were all considerably lower in honeybees that were administered propolis ethanol extract either before or after infection than in the positive control [156]. At the conclusion of this section, it should be noted that there are already licensed and commercially available plant essence products for the control of nosemiasis. Their efficacy has been proven in experimental studies. For example, a statistically significant decrease in the amount of N. ceranae spores was seen when the herbal supplements Nozemat Herb® and Nozemat Herb Plus® were used [59]. Additionally, employed as anti-N. ceranae therapy were the dietary supplements ApiHerb® and Api-Bioxal®. Both treatments reduced the frequency of infections and the quantity of N. ceranae, but ApiHerb® had a greater effect [157]. Therefore, with the provision of commercially available supplemental feeds (Apiherb®, Vita Feed Gold®), honeybee colonies may be energised and strengthened.

3.3. Ascosphaera apis

The fungus ascomycete Ascosphaera apis (A. apis) is the cause of chalkbrood disease or “ascospherosis”. Larvae of all castes can be affected, but there is a higher initial prevalence in drones. This usual spring disease weakens the colony by lowering its production and exposing it to additional diseases, such EFB. It seldom results in the mortality of the infected colony. Due to the lack of bacterial competition from various species of Bacilli and Penicilli that are often present in healthy hives, the chalkbrood disease may be observed more frequently in antibiotic-treated colonies [158]. Another cause underlying the occurrence of the disease can be found in incorrect thermoregulation. Due to the decreased heating capacity of the brood region, weak nuclei and colonies are the populations that are most in danger. For the same reason, drone larvae often found on the periphery of the brood chamber are the most affected. If the hive is densely occupied, honeybees will respond to the fungus by increasing the temperature within the nest (social fever) [159]. Regarding pathogenesis, larvae become infected by consuming A. apis spores dispersed in the environment along with food during their first few days of life (usually between the third and fourth day). These sprout in the intestinal lumen, most likely stimulated by the elevated CO2 content. The mycelium then starts to develop and breaks through the intestine’s walls, spreading throughout the rest of the body, often from the back to the front. In most cases, larvae die within two days after wax layer apposition or soon after. The larva then experiences dehydration, which causes calcification/mummification. The consistency changes from soft to rubbery to hard, as if calcified, over time, giving rise to the disease’s name. A vast array of products has been investigated for the control of the chalkbrood disease and, among them, many EOs have been tested. Gochnauer and Margetts’ 1979 study, one of the first, demonstrated via in vitro testing how citral and geraniol suppressed the development of the fungus A. apis by blocking its vegetative growth [160]. The antifungal properties of natural substances were still being studied by Calderone et al. in 1994. In particular, the authors evaluated eight plant extracts: bay oil (Pimenta racemosa), camphor, clove oil (Syzygium aromaticum), cinnamon oil (Cinnamomum sp.), citronellal (3,7-dimethyl-6-octenal), Spanish origanum oil (Thymus capitatus), α-terpinene (l-isopropyl-4-methyl-1,3-cyclohexadiene), and thymol (5-methyl-2-[l-methylethyl]phenol). At 100 ppm for 168 h, cinnamon oil completely prevented fungal proliferation. For 72 h at 100 ppm and for 168 h at 1000 ppm, origanum oil and thymol totally prevented proliferation. All growth was inhibited by bay oil, citronellal, and clove oil at 1000 ppm for 168 h. At 10,000 ppm, camphor prevented any growth for 168 h, whereas α-terpinene prevented any growth for 72 h but not for 168 h. In general, at concentrations below the threshold values, the degree of inhibition was dose-dependent [161]. Dellacasa et al. examined the fungicidal potential of eight oils in the A. apis vegetative cycle in 2003. They show that fungicidal action was present in varied degrees in the oils of Tessaria absinthioides, Aloysia gratissima, Heterotheca latifolia, Lippia juneliana, L. integrifolia, and L. turbinata but was absent in the oils of Baccharis coridifolia and Eupatorium patens [162]. In the same year, Davis and Ward, 2003, found Leptospermum petersonii F.M. Bailey (lemon-scented tea tree), Eucalyptus citriodora (Hook.) K.D. Hill and L.A.S. Johnson (lemon-scented Eucalyptus), Leptospermum scoparium J.R. Forst and G. Forst (manuka) to be effective in controlling A. apis [163]. Ruffinengo et al., 2006, discovered that Heterothalamus alienus oil-impregnated filter paper disks placed around colonies considerably inhibited the growth of A. apis by 51% compared to the control in a first trial and by 31% in a second [164]. In vitro growth of A. apis was also effectively inhibited by cinnamon, cloves, rose, thyme, and propolis, according to research by Abou El-Enain et al., 2009. Fennel, ginger, henna, onion, and wormwood oils, on the other hand, showed little inhibition in vitro. The pathogen’s development was not inhibited by amalaki, fenugreek, violet oils, or fennel honey plants in the same investigation [165]. Recently, the ability of EOs of orange, lemongrass, citronella, and cinnamon bark to control A. apis in both contact-dependent and contact-independent shared airspaces was investigated. All of the substances were discovered to considerably reduce mycelial growth at low concentrations, indicating the possibility of using these natural products to manage this and other specific fungal diseases [166]. Nardoni et al., 2018, verified that the dilutions tested of C. zeylanicum had no effect against A. apis; when assayed undiluted C. zeylanicum proved effective against A. apis [7,166,167]. Due to the high citral content of Litsea cubeba EO, monoterpene citral, which was also found in C. flexuosus EO, it looked to be quite effective in controlling A. apis [7]. According to reports, EOs with high geraniol concentration are active. Pelargonium graveolens’ antifungal properties later supported this conclusion [7]. Kloucek et al., 2012, examined the effectiveness of a large number of EOs, specifically 70, in the vapour phase for the treatment of disease caused by A. apis. The researchers found that 39 of the 70 EOs had an antifungal impact on A. apis. The EO vapours of Armoracia rusticana exhibited the strongest antifungal activity, followed by Thymus vulgaris, Cymbopogon flexosus, Origanum vulgare, and Allium sativum. Allyl isothiocyanate, citral, carvacrol, and diallyl sulphides were the major components of the most active EOs [168]. Pusceddu et al., 2021 evaluated the efficacy of several EOs against A. apis as well. Thymus herba-barona, Thymus capitatus, and Cinnamomum zeylanicum were the most efficacious EOs with the lowest fungicidal and sporicidal concentrations within 200 and 400 ppm. Thymus capitatus and Thymus herba-barona’s oils were mostly composed of carvacrol, whereas Cinnamomum zeylanicum’s oil was predominately composed of cinnamic aldehyde [169]. There were discrepant findings with S. aromaticum [7,168]. Instead, when combined, certain potent EOs, such as C. zeylanicum, C. flexuosus, P. graveolens, and L. cubeba (0.02% each and 0.015% each), showed a synergistic impact that significantly increased their efficacy against A. apis [7].

3.4. Viruses

Although the direct harm that V. destructor inflicts on larvae and adult honeybees by sucking haemolymph is unquestionably significant, it pales in comparison to the transfer of viruses, which is the primary reason for colony breakdown and death. Over time, it has become clearer that viruses have a function in the presence of V. destructor on hive mortality. Over 20 viruses have been detected thus far. The deformed wing virus (DWV) is now known to be the most dangerous. On mature honeybees, this virus may be present naturally and seldom causes issues. Adult honeybees with malformed wings are created when the virus is directly injected into the haemolymph of the larvae by the Varroa parasite. The ability of DWV to reproduce in the mite may account for the tremendous effectiveness of V. destructor in spreading this virus; in fact, the virus spreads widely even in areas with low infestation levels [170]. It has also been proposed that the occurrence is linked to an immunodepression condition in growing host honeybees, which would also better explain the interaction between the virus and the mites. The lifespan of the honeybees will be shortened if acute paralysis virus (ABPV), which is often innocuous in the absence of V. destructor, is also present at the same time. This is the reason why colonies perish in the winter yet often even the most badly afflicted colonies survive in the summer because they can produce honeybees to replace those who die too soon. Additionally, Varroa-infested colonies are significantly impacted by the Israeli acute paralysis virus (IAPV). Recently, it has been shown that this virus has detrimental effects on foragers’ behaviour, specifically on their capacity to returning to the hive (homing ability) [171,172,173]. According to experts, the IAPV virus infects a bee’s neurological system and prevents it from returning to the hive [172]. Since it may multiply in V. destructor and is sent back to the honeybees from them, its spread is correlated with the severity of the infection. It appears more common for honeybees to become sick with numerous viruses than just one, yet seeing an afflicted bee is often uncommon [174]. In order to prevent or at least lessen the danger of viral transmission, it is necessary to maintain a reasonable level of the V. destructor populations. In general, the risk of virus multiplication rises as Varroa populations and its feeding activities rise [170]. There are not many studies concerning the control of bee viruses by administering natural products. In a 2016 study by Aurori et al., the antiviral effectiveness of ethanolic extracts of leaves from Laurus nobilis on foraging honeybees that were naturally infected with the BQCV (black queen cell virus) was examined. Even at the lowest dosage examined (1 mg/mL), overall virus loads decreased after therapy. Significantly less viral replication was seen at higher extract concentrations (5 mg/mL) [175]. In a more recent study by Boncristiani et al., 2021, several compounds were studied to demonstrate their beneficial activities on DWV and VDV levels in honeybees [176]. Although not all of the items examined had consistent outcomes, the researchers did discover several that had an impact on viral loads. Interestingly, when honeybees were supplemented with NPs, raw cacao had a substantial impact on the amount of DWV and VDV. Chocolate is made from fermented, dried, and roasted cocoa beans, which are produced by the Theobroma cacao tree in tropical rainforests. Polyphenols, flavonols, and procyanidins are only a few of the many bioactive chemical substances found in cocoa beans [177,178]. Prior to roasting, many of these chemical components are present in greater quantities [179], However, this causes losses of up to 71% for the total phenolic compounds and 53–77% for the antioxidants [180,181]. The cocoa bean shells utilised in Boncristiani’s research were both unroasted and roasted [176]. With comparable 30-fold increases in viral loads, but in the reverse direction, DWV levels rose while VDV levels fell [176]. Citrus fruits like lemons and oranges, as well as several other fruits and vegetables, contain a major flavonoid called hesperidin [182]. Hesperidin greatly lowered VDV levels [176]. Instead, the others therapies that exhibited effects (chrysin, curcumin, limonene, tocopherol, tyrosine) showed no statistically significant variations of viral loads [176]. Another recent study examined the effects of grape marc powder (GPP) as a dietary supplement to strengthen honeybees with DWV-affected immune systems. According to the findings, GPP treatments improved honeybees’ ability to fight against DWV. When honeybees were infected with DWV and given GPP (doses of 0.5, 1, 2.5, and 5%), the viral load was substantially different from that of the inoculated honeybees who had not received the GPP supplementation. Furthermore, the expression of the Relish gene was much greater in honeybees given GPP compared to the infected control.

3.5. Varroa destructor

V. destructor parasitises adult honeybees and their larval forms. Particularly in the brood, V. destructor produces enormous damage, causing malformations and stunting the development of individuals [183]. The damage is due to parasitic action. V. destructor is in fact an ectoparasite that feeds mainly on the fat body of immature and adult honeybees [184]. In adults, it also produces behavioural alterations and reduced biological functions. All of this can quickly lead to colony collapse if action is not taken in a short time [185]. Various synthetic acaricide products have been created over the years, but mites have often developed resistance to them [186,187]. Synthetic products also accumulate in the food matrices of the hive, resulting in toxicity to honeybees and possible risks to the end consumer [188]. For this reason, NPs may be a promising alternative. For example, EOs have often demonstrated efficacy of action [189,190,191,192], and it is known that they are easily degraded in the environment without giving rise to accumulation phenomena [22]. Moreover, given their complex chemical composition, mite populations are unlikely to develop resistance to them [193]. The plant families Apiaceae, Asteraceae, Lamiaceae, Myrtaceae, Poaceae, and Verbenaceae have received the greatest attention in studies of EO activity. Pure EOs and isolated monoterpenes have both been used in tests against V. destrucor. The relationship of EOs with entomopathogenic fungi has instead been anticipated by specific association studies [194,195]. For each family that was researched, we provide a few studies along with the findings on their effectiveness below. In several independent laboratory studies, the acaricidal abilities of Syzygium aromaticum were examined for the family Myrtaceae. When used as a fumigant, S. aromaticum demonstrated a high degree of heterogeneity in effectiveness. Similar but much better results were obtained by Sammataro et al., 1998 [196], and Vieira et al., 2012 [197], compared to Xiao-Ling et al., 2012 [198]. While the second study group’s average mortality was 54%, the first two research groups’ average death was over 87%. Citrus spp. and Mentha spp. EOs both displayed comparable non-constant acaricidal efficacy. Acaricidal effectiveness from isolated EOs was shown to be excellent in some trials but not in others [8,197,199,200,201]. In laboratory investigations, plants from the species Pimpinella spp. and Foeniculum spp. of the Apiaceae family were assessed. Foeniculum spp. had a lower acaricidal capability, typically about 60% [37,189], compared to Pimpinella spp., which was reported to have an effectiveness of 92.5% in studies by Vieira et al., 2012 [197], and Xiao-Ling et al., 2012 [198]. Plants from the groups Verbenaceae, Lauraceae, and Poaceae have received little attention in research. The species Acantholippia seriphioides (aerial parts) of the Verbenaceae family was tested by Ruffinengo et al. in 2014 [202], and it showed a high acaricide efficiency of 99% via complete exposure and 87% via fumigation. The species Laurus nobilis [196] and Cinnamomum verum [197] were primarily investigated for the Lauraceae family. Particularly, Vieira et al., 2012, [197] discovered that Cinnamomum verum fumigation had only 52.50% acaricidal activity after 6 h of fume exposure. The same botanical family member, Laurus nobilis, produced superior results, achieving an acaricidal efficacy close to 75%. For the Lamiaceae family, in addition to thyme, which demonstrated consistently high acaricidal efficacy results in independent studies, oregano essential oil has also shown great promise [12,39,203,204].
Table 1 below summarises the botanical species object of the studies mentioned in the manuscript.

4. Discussion and Conclusions

In addition to summarising the NPs that have been reported in the literature for their positive effects for the control of hive pathogens, this scientific paper reviews the current state of research on the mechanism of action of EOs. They are already available in the beekeeper’s kit for controlling the V. destructor parasite. In particular, the pharmacological preparations on the market are based on thymol. In this literature review, it was observed that thymol is also effective in the control of bacterial, fungal, and viral infections. In addition to thymol, several other compounds have shown promise for pathogen control. These NPs could be used more systematically in the future. However, some obstacles must be overcome for their use. Natural compounds have different chemical compositions depending on the period and place of the harvesting of the plants from which they are extracted. Furthermore, NPs have chemical structures and numerous chiral centres that make their synthesis difficult. When isolated directly from their main biological resource, the extraction method can influence the presence of certain molecules. The lack of standardised criteria and standards in the present research on NPs might result in underdeveloped methods for assessing their efficacy and possibly confusing procedures. Another issue is that only small quantities of products are often isolated. The evaluation of compounds that can only be obtained in small quantities often takes place with difficulty and over a long time. Miniaturised bioassays have been created to overcome this problem. Large-scale research should be conducted to examine the interactions between dietary supplements and their antagonists. In reality, we have found that there are not many association studies. Additionally, when exposed to oxidizing environmental factors like sun and air, natural chemicals are very labile. Therefore, it is vital to use technologies that safeguard preparations. We may state as a conclusion that further study is required to address the challenges associated with the usage of NPs.

Author Contributions

Conceptualisation, R.B. and F.C. (Fabio Castagna); methodology, R.B., F.C. (Fabio Castagna), G.S., B.D. and E.P.; writing—original draft preparation, R.B., F.C. (Fabio Castagna), S.R., S.N., R.C., M.S., R.M.B., C.L., M.M., F.C. (Filomena Conforti), G.S., B.D. and E.P.; writing—review and editing, R.B., F.C. (Fabio Castagna), S.R., S.N., R.C., M.S., R.M.B., C.L., M.M., F.C. (Filomena Conforti), G.S., B.D. and E.P.; supervision, G.S., B.D. and E.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Klein, A.-M.; Vaissiere, B.E.; Cane, J.H.; Steffan-Dewenter, I.; Cunningham, S.A.; Kremen, C.; Tscharntke, T. Importance of pollinators in changing landscapes for world crops. Proc. R. Soc. B Biol. Sci. 2007, 274, 303–313. [Google Scholar] [CrossRef] [PubMed]
  2. Gallai, N.; Salles, J.-M.; Settele, J.; Vaissière, B.E. Economic valuation of the vulnerability of world agriculture confronted with pollinator decline. Ecol. Econ. 2009, 68, 810–821. [Google Scholar] [CrossRef]
  3. Potts, S.G.; Biesmeijer, J.C.; Kremen, C.; Neumann, P.; Schweiger, O.; Kunin, W.E. Global pollinator declines: Trends, impacts and drivers. Trends Ecol. Evol. 2010, 25, 345–353. [Google Scholar] [CrossRef] [PubMed]
  4. Il’iasov, R.A.; Gaǐfullina, L.R.; Saltykova, E.S.; Poskriakov, A.V.; Nikolenko, A.G. Defensins in the honeybee antinfectious protection. Zhurnal Evoliutsionnoi Biokhimii I Fiziol. 2012, 48, 425–432. [Google Scholar]
  5. Lu, H.L.; St. Leger, R.J. Insect Immunity to Entomopathogenic Fungi. Adv. Genet. 2016, 94, 251–285. [Google Scholar] [CrossRef]
  6. Bava, R.; Castagna, F.; Piras, C.; Musolino, V.; Lupia, C.; Palma, E.; Britti, D.; Musella, V. Entomopathogenic Fungi for Pests and Predators Control in Beekeeping. Vet. Sci. 2022, 9, 95. [Google Scholar] [CrossRef]
  7. Nardoni, S.; D’Ascenzi, C.; Rocchigiani, G.; Papini, R.A.; Pistelli, L.; Formato, G.; Najar, B.; Mancianti, F. Stonebrood and chalkbrood in Apis mellifera causing fungi: In vitro sensitivity to some essential oils. Nat. Prod. Res. 2018, 32, 385–390. [Google Scholar] [CrossRef]
  8. Bava, R.; Castagna, F.; Piras, C.; Palma, E.; Cringoli, G.; Musolino, V.; Lupia, C.; Perri, M.R.; Statti, G.; Britti, D.; et al. In vitro evaluation of acute toxicity of five Citrus spp. Essential oils towards the parasitic mite Varroa destructor. Pathogens 2021, 10, 1182. [Google Scholar] [CrossRef]
  9. Formato, G.; Rivera-Gomis, J.; Bubnic, J.; Martín-Hernández, R.; Milito, M.; Croppi, S.; Higes, M. Nosemosis Prevention and Control. Appl. Sci. 2022, 12, 783. [Google Scholar] [CrossRef]
  10. Carreck, N.L.; Ball, B.V.; Martin, S.J. Honey bee colony collapse and changes in viral prevalence associated with Varroa destructor. J. Apic. Res. 2010, 49, 93–94. [Google Scholar] [CrossRef]
  11. Parveen, N.; Miglani, R.; Kumar, A.; Dewali, S.; Kumar, K.; Sharma, N.; Bisht, S.S. Honey bee pathogenesis posing threat to its global population: A short review. Proc. Indian Natl. Sci. Acad. 2022, 88, 11–32. [Google Scholar] [CrossRef]
  12. Castagna, F.; Bava, R.; Piras, C.; Carresi, C.; Musolino, V.; Lupia, C.; Marrelli, M.; Conforti, F.; Palma, E.; Britti, D. Green Veterinary Pharmacology for Honey Bee Welfare and Health: Origanum heracleoticum L. (Lamiaceae) Essential Oil for the Control of the Apis mellifera Varroatosis. Vet. Sci. 2022, 9, 124. [Google Scholar] [CrossRef] [PubMed]
  13. Mutinelli, F. European legislation governing the authorization of veterinary medicinal products with particular reference to the use of drugs for the control of honey bee diseases. Apiacta 2003, 38, 156–168. [Google Scholar]
  14. Li, F.-S.; Weng, J.-K. Demystifying traditional herbal medicine with modern approach. Nat. Plants 2017, 3, 17109. [Google Scholar] [CrossRef] [PubMed]
  15. Boadu, A.A.; Asase, A. Documentation of herbal medicines used for the treatment and management of human diseases by some communities in southern Ghana. Evid.-Based Complement. Altern. Med. 2017, 2017, 3043061. [Google Scholar] [CrossRef]
  16. Lin, J.H.; Kaphle, K.; Wu, L.S.; Yang, N.Y.J.; Lu, G.; Yu, C.; Yamada, H.; Rogers, P.A.M. Sustainable veterinary medicine for the new era. Rev. Sci. Tech. Int. Des Épizooties 2003, 22, 949–964. [Google Scholar] [CrossRef]
  17. Bosco, F.; Ruga, S.; Citraro, R.; Leo, A.; Guarnieri, L.; Maiuolo, J.; Oppedisano, F.; Macrì, R.; Scarano, F.; Nucera, S. The Effects of Andrographis paniculata (Burm. F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases. Nutrients 2023, 15, 3428. [Google Scholar] [CrossRef]
  18. Maiuolo, J.; Bulotta, R.M.; Oppedisano, F.; Bosco, F.; Scarano, F.; Nucera, S.; Guarnieri, L.; Ruga, S.; Macri, R.; Caminiti, R. Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders. Life 2022, 13, 77. [Google Scholar] [CrossRef]
  19. Štrbac, F.; Bosco, A.; Maurelli, M.P.; Ratajac, R.; Stojanović, D.; Simin, N.; Orčić, D.; Pušić, I.; Krnjajić, S.; Sotiraki, S.; et al. Anthelmintic Properties of Essential Oils to Control Gastrointestinal Nematodes in Sheep—In Vitro and In Vivo Studies. Vet. Sci. 2022, 9, 93. [Google Scholar] [CrossRef]
  20. Castagna, F.; Bava, R.; Musolino, V.; Piras, C.; Cardamone, A.; Carresi, C.; Lupia, C.; Bosco, A.; Rinaldi, L.; Cringoli, G. Potential new therapeutic approaches based on Punica granatum fruits compared to synthetic anthelmintics for the sustainable control of gastrointestinal nematodes in sheep. Animals 2022, 12, 2883. [Google Scholar] [CrossRef]
  21. Rosell, G.; Quero, C.; Coll, J.; Guerrero, A. Biorational insecticides in pest management. J. Pestic. Sci. 2008, 33, 103–121. [Google Scholar] [CrossRef]
  22. Isman, M.B. Plant essential oils for pest and disease management. Crop Prot. 2000, 19, 603–608. [Google Scholar] [CrossRef]
  23. Grdiša, M.; Gršić, K. Botanical insecticides in plant protection. Agric. Conspec. Sci. 2013, 78, 85–93. [Google Scholar]
  24. Parimelazhagan, T. Pharmacological Assays of Plant-Based Natural Products; Springer: Berlin/Heidelberg, Germany, 2015; Volume 71, ISBN 3319268112. [Google Scholar]
  25. Balandrin, M.F.; Kinghorn, A.D.; Farnsworth, N.R. Plant-derived natural products in drug discovery and development: An overview. In Human Medicinal Agents from Plants; ACS Publications: Washington, DC, USA, 1993. [Google Scholar]
  26. Elliott, M.; Chithan, K. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In The Flavonoids Advances in Research Since 1986; Routledge: London, UK, 2017; pp. 619–652. [Google Scholar]
  27. Khanikor, B.; Bora, D. Effect of plant based essential oil on immune response of silkworm, Antheraea assama Westwood (Lepidoptera: Saturniidae). Int. J. Ind. Entomol. 2012, 25, 139–146. [Google Scholar] [CrossRef]
  28. Lee, A.N.; Werth, V.P. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch. Dermatol. 2004, 140, 723–727. [Google Scholar] [CrossRef]
  29. Grela, E.R.; Sembratowicz, I.; Czech, A. Immunostimmulatory activity of herbs. Med. Weter. 1998, 54, 152–158. [Google Scholar]
  30. Mollace, V.; Sacco, I.; Janda, E.; Malara, C.; Ventrice, D.; Colica, C.; Visalli, V.; Muscoli, S.; Ragusa, S.; Muscoli, C. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: From animal models to human studies. Fitoterapia 2011, 82, 309–316. [Google Scholar] [CrossRef]
  31. Gliozzi, M.; Macrì, R.; Coppoletta, A.R.; Musolino, V.; Carresi, C.; Scicchitano, M.; Bosco, F.; Guarnieri, L.; Cardamone, A.; Ruga, S. From diabetes care to heart failure management: A potential therapeutic approach combining SGLT2 inhibitors and plant extracts. Nutrients 2022, 14, 3737. [Google Scholar] [CrossRef]
  32. Maiuolo, J.; Musolino, V.; Guarnieri, L.; Macrì, R.; Coppoletta, A.R.; Cardamone, A.; Serra, M.; Gliozzi, M.; Bava, I.; Lupia, C. Ferula communis L.(Apiaceae) Root Acetone-Water Extract: Phytochemical Analysis, Cytotoxicity and In Vitro Evaluation of Estrogenic Properties. Plants 2022, 11, 1905. [Google Scholar] [CrossRef]
  33. Catella, C.; Camero, M.; Lucente, M.S.; Fracchiolla, G.; Sblano, S.; Tempesta, M.; Martella, V.; Buonavoglia, C.; Lanave, G. Virucidal and antiviral effects of Thymus vulgaris essential oil on feline coronavirus. Res. Vet. Sci. 2021, 137, 44–47. [Google Scholar] [CrossRef]
  34. Piras, C.; Tilocca, B.; Castagna, F.; Roncada, P.; Britti, D.; Palma, E. Plants with Antimicrobial Activity Growing in Italy: A Pathogen-Driven Systematic Review for Green Veterinary Pharmacology Applications. Antibiotics 2022, 11, 919. [Google Scholar] [CrossRef] [PubMed]
  35. Alippi, A.M.; Ringuelet, J.A.; Cerimele, E.L.; Re, M.S.; Henning, C.P. Antimicrobial activity of some essential oils against Paenibacillus larvae, the causal agent of American foulbrood disease. J. Herbs. Spices Med. Plants 1996, 4, 9–16. [Google Scholar] [CrossRef]
  36. Fuselli, S.R.; de la Rosa, S.B.G.; Gende, L.B.; Eguaras, M.J.; Fritz, R. Antimicrobial activity of some Argentinean wild plant essential oils against Paenibacillus larvae larvae, causal agent of American foulbrood (AFB). J. Apic. Res. 2006, 45, 2–7. [Google Scholar] [CrossRef]
  37. Bava, R.; Castagna, F.; Palma, E.; Musolino, V.; Carresi, C.; Cardamone, A.; Lupia, C.; Marrelli, M.; Conforti, F.; Roncada, P. Phytochemical Profile of Foeniculum vulgare Subsp. piperitum Essential Oils and Evaluation of Acaricidal Efficacy against Varroa destructor in Apis mellifera by In Vitro and Semi-Field Fumigation Tests. Vet. Sci. 2022, 9, 684. [Google Scholar] [CrossRef]
  38. Bendifallah, L.; Belguendouz, R.; Hamoudi, L.; Arab, K. Biological activity of the Salvia officinalis L. (Lamiaceae) essential oil on Varroa destructor infested honeybees. Plants 2018, 7, 44. [Google Scholar] [CrossRef]
  39. Sabahi, Q.; Gashout, H.; Kelly, P.G.; Guzman-Novoa, E. Continuous release of oregano oil effectively and safely controls Varroa destructor infestations in honey bee colonies in a northern climate. Exp. Appl. Acarol. 2017, 72, 263–275. [Google Scholar] [CrossRef]
  40. Knobloch, K.; Pauli, A.; Iberl, B.; Weigand, H.; Weis, N. Antibacterial and antifungal properties of essential oil components. J. Essent. Oil Res. 1989, 1, 119–128. [Google Scholar] [CrossRef]
  41. Knobloch, K.; Weigand, H.; Weis, N.; Schwarm, H.M.; Vigenschow, H. Action of Terpenoids on Energy Metabolism; Walter de Gruyter: Berlin, Germany, 1986. [Google Scholar]
  42. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004, 94, 223–253. [Google Scholar] [CrossRef]
  43. Denyer, S.P. Biocide-induced damage to the bacterial cytoplasmic membrane. Mech. Action Chem. Biocides 1991, 27, 171–187. [Google Scholar]
  44. Lambert, R.J.W.; Skandamis, P.N.; Coote, P.J.; Nychas, G. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol. 2001, 91, 453–462. [Google Scholar] [CrossRef]
  45. Weidenmaier, C.; Peschel, A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 2008, 6, 276–287. [Google Scholar] [CrossRef] [PubMed]
  46. Ratledge, C.; Wilkinson, S.G. Microbial Lipids; Academic Press: Cambridge, MA, USA, 1988; Volume 1. [Google Scholar]
  47. Devi, K.P.; Nisha, S.A.; Sakthivel, R.; Pandian, S.K. Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane. J. Ethnopharmacol. 2010, 130, 107–115. [Google Scholar] [CrossRef] [PubMed]
  48. Zhou, K.; Zhou, W.; Li, P.; Liu, G.; Zhang, J.; Dai, Y. Mode of action of pentocin 31-1: An antilisteria bacteriocin produced by Lactobacillus pentosus from Chinese traditional ham. Food Control 2008, 19, 817–822. [Google Scholar] [CrossRef]
  49. Denyer, S.P.; Hugo, W.B. Mechanisms of antibacterial action-a summary. Soc. Appl. Bacteriol. Tech. Ser. 1991, 27, 331–334. [Google Scholar]
  50. Sikkema, J.A.N.; de Bont, J.A.; Poolman, B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 1995, 59, 201–222. [Google Scholar] [CrossRef]
  51. Dorman, H.; Deans, S.G. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J. Appl. Microbiol. 2000, 88, 308–316. [Google Scholar] [CrossRef]
  52. Ultee, A.; Bennik, M.H.J.; Moezelaar, R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 2002, 68, 1561–1568. [Google Scholar] [CrossRef]
  53. Juven, B.J.; Kanner, J.; Schved, F.; Weisslowicz, H. Factors that interact with the antibacterial action of thyme essential oil and its active constituents. J. Appl. Bacteriol. 1994, 76, 626–631. [Google Scholar] [CrossRef]
  54. Holetz, F.B.; Pessini, G.L.; Sanches, N.R.; Cortez, D.A.G.; Nakamura, C.V.; Dias Filho, B.P. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem. Inst. Oswaldo Cruz 2002, 97, 1027–1031. [Google Scholar] [CrossRef]
  55. Yutani, M.; Hashimoto, Y.; Ogita, A.; Kubo, I.; Tanaka, T.; Fujita, K. Morphological changes of the filamentous fungus Mucor mucedo and inhibition of chitin synthase activity induced by anethole. Phyther. Res. 2011, 25, 1707–1713. [Google Scholar] [CrossRef]
  56. Gogoi, P.; Baruah, P.; Nath, S.C. Microbiological Research. Effects of Citrus sinensis (L.) Osbeck epicarp essential oil on growth and morphogenesis of Aspergillus niger (L.) Van Tieghem. Microbiol. Res. 2008, 163, 337–344. [Google Scholar]
  57. İşcan, G.; İşcan, A.; Demirci, F. Anticandidal effects of thymoquinone: Mode of action determined by transmission electron microscopy (TEM). Nat. Prod. Commun. 2016, 11, 1934578X1601100726. [Google Scholar] [CrossRef]
  58. Karpiński, T.M. Essential oils of Lamiaceae family plants as antifungals. Biomolecules 2020, 10, 103. [Google Scholar] [CrossRef] [PubMed]
  59. D’auria, F.D.; Tecca, M.; Strippoli, V.; Salvatore, G.; Battinelli, L.; Mazzanti, G. Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Med. Mycol. 2005, 43, 391–396. [Google Scholar] [CrossRef] [PubMed]
  60. de Sant’Anna, J.R.; da Silva Franco, C.C.; Miyamoto, C.T.; Cunico, M.M.; Miguel, O.G.; Côcco, L.C.; Yamamoto, C.I.; Junior, C.C.; de Castro-Prado, M.A.A. Genotoxicity of Achillea millefolium essential oil in diploid cells of Aspergillus nidulans. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2009, 23, 231–235. [Google Scholar]
  61. Chen, Y.; Zeng, H.; Tian, J.; Ban, X.; Ma, B.; Wang, Y. Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. J. Med. Microbiol. 2013, 62, 1175–1183. [Google Scholar] [CrossRef]
  62. Haque, E.; Irfan, S.; Kamil, M.; Sheikh, S.; Hasan, A.; Ahmad, A.; Lakshmi, V.; Nazir, A.; Mir, S.S. Terpenoids with antifungal activity trigger mitochondrial dysfunction in Saccharomyces cerevisiae. Microbiology 2016, 85, 436–443. [Google Scholar] [CrossRef]
  63. Perlin, D.S.; Seto-Young, D.; Monk, B.C. The plasma membrane H (+)-ATPase of fungi. A candidate drug target? Ann. N. Y. Acad. Sci. 1997, 834, 609–617. [Google Scholar] [CrossRef]
  64. Ahmad, A.; Khan, A.; Manzoor, N. Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. Eur. J. Pharm. Sci. 2013, 48, 80–86. [Google Scholar] [CrossRef]
  65. Wani, A.R.; Yadav, K.; Khursheed, A.; Rather, M.A. An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses. Microb. Pathog. 2021, 152, 104620. [Google Scholar] [CrossRef]
  66. Vimalanathan, S.; Hudson, J. Anti-influenza virus activity of essential oils and vapors. Am. J. Essent. Oils Nat. Prod. 2014, 2, 47–53. [Google Scholar]
  67. Ma, L.; Yao, L. Antiviral effects of plant-derived essential oils and their components: An updated review. Molecules 2020, 25, 2627. [Google Scholar] [CrossRef]
  68. Feriotto, G.; Marchetti, N.; Costa, V.; Beninati, S.; Tagliati, F.; Mischiati, C. Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function. Chem. Biodivers. 2018, 15, e1700436. [Google Scholar] [CrossRef] [PubMed]
  69. Wu, S.; Patel, K.B.; Booth, L.J.; Metcalf, J.P.; Lin, H.-K.; Wu, W. Protective essential oil attenuates influenza virus infection: An in vitro study in MDCK cells. BMC Complement. Altern. Med. 2010, 10, 1–13. [Google Scholar] [CrossRef] [PubMed]
  70. Setzer, W.N. Essential oils as complementary and alternative medicines for the treatment of influenza. Am. J. Essent. Oil Nat. Prod 2016, 4, 16–22. [Google Scholar]
  71. Nagy, M.M.; Al-Mahdy, D.A.; Abd El Aziz, O.M.; Kandil, A.M.; Tantawy, M.A.; El Alfy, T.S.M. Chemical composition and antiviral activity of essential oils from Citrus reshni hort. ex Tanaka (Cleopatra mandarin) cultivated in Egypt. J. Essent. Oil Bear. Plants 2018, 21, 264–272. [Google Scholar] [CrossRef]
  72. Ortega-Cuadros, M.; de Guevara, E.E.A.; Castillo, A.D.M.; Castañeda, C.G.; Amarís, G.C.; Tofiño-Rivera, A.P. Actividad biologica de los aceites esenciales del arbusto Lippia alba (Verbenaceae). Rev. Biol. Trop. 2020, 68, 344–360. [Google Scholar]
  73. Jackwood, M.W.; Rosenbloom, R.; Petteruti, M.; Hilt, D.A.; McCall, A.W.; Williams, S.M. Avian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivo. Virus Res. 2010, 149, 86–94. [Google Scholar] [CrossRef]
  74. Shaddel-Telli, A.-A.; Maheri-Sis, N.; Aghajanzadeh-Golshani, A.; Asadi-Dizaji, A.; Cheragi, H.; Mousavi, M. Using medicinal plants for controlling Varroa mite in honey bee colonies. J. Anim. Vet. Adv 2008, 7, 328–330. [Google Scholar]
  75. Gonzalez-Gomez, R.; Otero-Colina, G.; Villanueva-Jiménez, J.A.; Pérez-Amaro, J.A.; Soto-Hernández, R.M. Azadirachta indica toxicity and repellence of Varroa destructor (Acari: Varroidae). Agrociencia 2006, 40, 741–751. [Google Scholar]
  76. Schenk, P.; Imdorf, A.; Fluri, P. Effects of neem oil on Varroa mites and bees. Am. Bee J. 2001, 141, 878–879. [Google Scholar]
  77. Melathopoulos, A.P.; Winston, M.L.; Whittington, R.; Higo, H.; Le Doux, M. Field evaluation of neem and canola oil for the selective control of the honey bee (Hymenoptera: Apidae) mite parasites Varroa jacobsoni (Acari: Varroidae) and Acarapis woodi (Acari: Tarsonemidae). J. Econ. Entomol. 2000, 93, 559–567. [Google Scholar] [CrossRef]
  78. Nerio, L.S.; Olivero-Verbel, J.; Stashenko, E. Repellent activity of essential oils: A review. Bioresour. Technol. 2010, 101, 372–378. [Google Scholar] [CrossRef] [PubMed]
  79. Waliwitiya, R.; Kennedy, C.J.; Lowenberger, C.A. Larvicidal and oviposition-altering activity of monoterpenoids, trans-anithole and rosemary oil to the yellow fever mosquito Aedes aegypti (Diptera: Culicidae). Pest Manag. Sci. Former. Pestic. Sci. 2009, 65, 241–248. [Google Scholar] [CrossRef] [PubMed]
  80. Rajendran, S.; Sriranjini, V. Plant products as fumigants for stored-product insect control. J. Stored Prod. Res. 2008, 44, 126–135. [Google Scholar] [CrossRef]
  81. Isman, M.B. Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world. Annu. Rev. Entomol. 2006, 51, 45–66. [Google Scholar] [CrossRef]
  82. Ryan, M.F.; Byrne, O. Plant-insect coevolution and inhibition of acetylcholinesterase. J. Chem. Ecol. 1988, 14, 1965–1975. [Google Scholar] [CrossRef]
  83. Orhan, I.; Şenol, F.S.; Gülpinar, A.R.; Kartal, M.; Şekeroglu, N.; Deveci, M.; Kan, Y.; Şener, B. Acetylcholinesterase inhibitory and antioxidant properties of Cyclotrichium niveum, Thymus praecox subsp. caucasicus var. caucasicus, Echinacea purpurea and E. pallida. Food Chem. Toxicol. 2009, 47, 1304–1310. [Google Scholar] [CrossRef]
  84. Perry, N.S.L.; Houghton, P.J.; Jenner, P.; Keith, A.; Perry, E.K. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine 2002, 9, 48–51. [Google Scholar] [CrossRef]
  85. Kang, J.S.; Kim, E.; Lee, S.H.; Park, I.K. Inhibition of acetylcholinesterases of the pinewood nematode, Bursaphelenchus xylophilus, by phytochemicals from plant essential oils. Pestic. Biochem. Physiol. 2013, 105, 50–56. [Google Scholar] [CrossRef]
  86. Yeom, H.J.; Jung, C.S.; Kang, J.; Kim, J.; Lee, J.H.; Kim, D.S.; Kim, H.S.; Park, P.S.; Kang, K.S.; Park, I.K. Insecticidal and acetylcholine esterase inhibition activity of asteraceae plant essential oils and their constituents against adults of the German cockroach (blattella germanica). J. Agric. Food Chem. 2015, 63, 2241–2248. [Google Scholar] [CrossRef] [PubMed]
  87. Picollo, M.I.; Toloza, A.C.; Mougabure Cueto, G.; Zygadlo, J.; Zerba, E. Anticholinesterase and pediculicidal activities of monoterpenoids. Fitoterapia 2008, 79, 271–278. [Google Scholar] [CrossRef] [PubMed]
  88. Seo, S.-M.; Kim, J.; Kang, J.; Koh, S.-H.; Ahn, Y.-J.; Kang, K.-S.; Park, I.-K. Fumigant toxicity and acetylcholinesterase inhibitory activity of 4 Asteraceae plant essential oils and their constituents against Japanese termite (Reticulitermes speratus Kolbe). Pestic. Biochem. Physiol. 2014, 113, 55–61. [Google Scholar] [CrossRef] [PubMed]
  89. Park, C.G.; Jang, M.; Yoon, K.A.; Kim, J. Insecticidal and acetylcholinesterase inhibitory activities of Lamiaceae plant essential oils and their major components against Drosophila suzukii (Diptera: Drosophilidae). Ind. Crops Prod. 2016, 89, 507–513. [Google Scholar] [CrossRef]
  90. Reegan, A.D.; Stalin, A.; Paulraj, M.G.; Balakrishna, K.; Ignacimuthu, S.; Al-Dhabi, N.A. In silico molecular docking of niloticin with acetylcholinesterase 1 (AChE1) of Aedes aegypti L. (Diptera: Culicidae): A promising molecular target. Med. Chem. Res. 2016, 25, 1411–1419. [Google Scholar] [CrossRef]
  91. Anderson, J.A.; Coats, J.R. Acetylcholinesterase inhibition by nootkatone and carvacrol in arthropods. Pestic. Biochem. Physiol. 2012, 102, 124–128. [Google Scholar] [CrossRef]
  92. Enan, E. Insecticidal activity of essential oils: Octopaminergic sites of action. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2001, 130, 325–337. [Google Scholar] [CrossRef]
  93. Enan, E.E. Molecular and pharmacological analysis of an octopamine receptor from American cockroach and fruit fly in response to plant essential oils. Arch. Insect Biochem. Physiol. 2005, 59, 161–171. [Google Scholar] [CrossRef]
  94. Price, D.N.; Berry, M.S. Comparison of effects of octopamine and insecticidal essential oils on activity in the nerve cord, foregut, and dorsal unpaired median neurons of cockroaches. J. Insect Physiol. 2006, 52, 309–319. [Google Scholar] [CrossRef]
  95. Kostyukovsky, M.; Rafaeli, A.; Gileadi, C.; Demchenko, N.; Shaaya, E. Activation of octopaminergic receptors by essential oil constituents isolated from aromatic plants: Possible mode of action against insect pests. Pest Manag. Sci. 2002, 58, 1101–1106. [Google Scholar] [CrossRef]
  96. Pflüger, H.-J.; Stevenson, P.A. Evolutionary aspects of octopaminergic systems with emphasis on arthropods. Arthropod Struct. Dev. 2005, 34, 379–396. [Google Scholar] [CrossRef]
  97. Enan, E.E. Insecticidal action of terpenes and phenols to the cockroaches: Effect on octopamine receptors. In Proceedings of the International Symposium on Crop Protection, Gent, Belgium, 5 May 1998. [Google Scholar]
  98. Priestley, C.M.; Williamson, E.M.; Wafford, K.A.; Sattelle, D.B. Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABAA receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster. Br. J. Pharmacol. 2003, 140, 1363–1372. [Google Scholar] [CrossRef]
  99. Hansen, H.; Brødsgaard, C.J. American foulbrood: A review of its biology, diagnosis and control. Bee World 1999, 80, 5–23. [Google Scholar] [CrossRef]
  100. Ellis, J.D.; Munn, P.A. The worldwide health status of honey bees. Bee World 2005, 86, 88–101. [Google Scholar] [CrossRef]
  101. Genersch, E. American Foulbrood in honeybees and its causative agent, Paenibacillus larvae. J. Invertebr. Pathol. 2010, 103, S10–S19. [Google Scholar] [CrossRef] [PubMed]
  102. Bamrick, J.F. Resistance to American foulbrood in honey bees: VI. Spore germination in larvae of different ages. J. Invertebr. Pathol. 1967, 9, 30–34. [Google Scholar] [CrossRef]
  103. Davidson, E.W. Ultrastructure of American foulbrood disease pathogenesis in larvae of the worker honey bee, Apis mellifera. J. Invertebr. Pathol. 1973, 21, 53–61. [Google Scholar] [CrossRef]
  104. Yue, D.; Nordhoff, M.; Wieler, L.H.; Genersch, E. Fluorescence in situ hybridization (FISH) analysis of the interactions between honeybee larvae and Paenibacillus larvae, the causative agent of American foulbrood of honeybees (Apis mellifera). Environ. Microbiol. 2008, 10, 1612–1620. [Google Scholar] [CrossRef]
  105. Thompson, H.M.; Waite, R.J.; Wilkins, S.; Brown, M.A.; Bigwood, T.; Shaw, M.; Ridgway, C.; Sharman, M. Effects of European foulbrood treatment regime on oxytetracycline levels in honey extracted from treated honeybee (Apis mellifera) colonies and toxicity to brood. Food Addit. Contam. 2005, 22, 573–578. [Google Scholar] [CrossRef]
  106. Thompson, H.M.; Brown, M.A. Is contact colony treatment with antibiotics an effective control for European foulbrood? Bee World 2001, 82, 130–138. [Google Scholar] [CrossRef]
  107. Bailey, L. The pathogenicity for honey-bee larvae of microorganisms associated with European foulbrood. J. Insect Pathol. 1963, 5, 198–205. [Google Scholar]
  108. Otten, C. A general overview on AFB and EFB pathogen, way of infection, multiplication, clinical symptoms and outbreak. Apiacta 2003, 38, 106–113. [Google Scholar]
  109. Bailey, L. European foulbrood. Am. Bee J. 1961, 101, 89–92. [Google Scholar]
  110. Forsgren, E.; Locke, B.; Sircoulomb, F.; Schäfer, M.O. Bacterial diseases in honeybees. Curr. Clin. Microbiol. Rep. 2018, 5, 18–25. [Google Scholar] [CrossRef]
  111. Mutinelli, F. The spread of pathogens through trade in honey bees and their products (including queen bees and semen): Overview and recent developments. Rev. Sci. Tech. 2011, 30, 257. [Google Scholar] [CrossRef]
  112. Murat, G.; Ferat, G. Stress Factors on Honey Bees (Apis mellifera L.) and The Components of Their Defense System Against Diseases, Parasites, and Pests. Mellifera 2019, 19, 7–20. [Google Scholar]
  113. Forsgren, E. European foulbrood in honey bees. J. Invertebr. Pathol. 2010, 103, S5–S9. [Google Scholar] [CrossRef] [PubMed]
  114. Ribarits, A.; Riegler, B.; Köglberger, H.; Derakhshifar, I.; Moosbeckhofer, R. 3. European Foulbrood (EFB). Guidel. Sustain. Manag. Honey Bee Dis. Eur. 2020, 24, 22–26. [Google Scholar]
  115. Pietropaoli, M.; Skerl, M.S.; Cazier, J.; Riviere, M.-P.; Tiozzo, B.; Eggenhoeffner, R.; Gregorc, A.; Haefeker, W.; Higes, M.; Ribarits, A.; et al. BPRACTICES Project: Towards a Sustainable European Beekeeping. Bee World 2020, 97, 66–69. [Google Scholar] [CrossRef]
  116. Lewis, K.; Ausubel, F.M. Prospects for plant-derived antibacterials. Nat. Biotechnol. 2006, 24, 1504–1507. [Google Scholar] [CrossRef]
  117. Damiani, N.; Fernández, N.J.; Porrini, M.P.; Gende, L.B.; Álvarez, E.; Buffa, F.; Brasesco, C.; Maggi, M.D.; Marcangeli, J.A.; Eguaras, M.J. Laurel leaf extracts for honeybee pest and disease management: Antimicrobial, microsporicidal, and acaricidal activity. Parasitol. Res. 2014, 113, 701–709. [Google Scholar] [CrossRef] [PubMed]
  118. Fuselli, S.R.; SB, G.D.L.R.; Gende, L.B.; Eguaras, M.J.; Fritz, R. Inhibition of Paenibacillus larvae employing a mixture of essential oils and thymol. Rev. Argent. Microbiol. 2006, 38, 89–92. [Google Scholar] [PubMed]
  119. Santos, R.C.V.; dos Santos Alves, C.F.; Schneider, T.; Lopes, L.Q.S.; Aurich, C.; Giongo, J.L.; Brandelli, A.; de Almeida Vaucher, R. Antimicrobial activity of Amazonian oils against Paenibacillus species. J. Invertebr. Pathol. 2012, 109, 265–268. [Google Scholar] [CrossRef]
  120. Alippi, A.M. Ensayos de Campo para la evaluar efectividad de algunos aceites esenciales [Field trials for evaluation of some essential oils efficiency]. Vida Apic. 2001, 108, 41–46. [Google Scholar]
  121. Fuselli, S.R.; Gende, L.B.; de la Rosa, S.B.G.; Eguaras, M.J.; Fritz, R. Inhibition of Paenibacillus larvae subsp. larvae by the essential oils of two wild plants and their emulsifying agents. Span. J. Agric. Res. 2005, 3, 220–224. [Google Scholar] [CrossRef]
  122. Kloucek, P.; Flesar, J.; Kokoska, L.; Nedorostová, L.; Titera, D. Activity of essential oils in vapour phase against Paenibacillus larvae. Planta Med. 2008, 74, PE27. [Google Scholar] [CrossRef]
  123. Gende, L.B.; Maggi, M.D.; Damiani, N.; Fritz, R.; Eguaras, M.J.; Floris, I. Advances in the apiary control of the honeybee American Foulbrood with Cinnamon (Cinnamomum zeylanicum) essential oil. Bull. Insectology 2009, 62, 93–97. [Google Scholar]
  124. Cecotti, R.; Carpana, E.; Falchero, L.; Paoletti, R.; Tava, A. Determination of the volatile fraction of Polygonum bistorta L. at different growing stages and evaluation of its antimicrobial activity against two major honeybee (Apis mellifera) pathogens. Chem. Biodivers. 2012, 9, 359–369. [Google Scholar] [CrossRef] [PubMed]
  125. Kuzyšinová, K.; Mudroňová, D.; Toporčák, J.; Nemcová, R.; Molnár, L.; Maďari, A.; Vaníková, S.; Kožár, M. Testing of inhibition activity of essential oils against Paenibacillus larvae—The causative agent of American foulbrood. Acta Vet. Brno 2014, 83, 9–12. [Google Scholar] [CrossRef]
  126. Pellegrini, M.C.; Alonso-Salces, R.M.; Umpierrez, M.L.; Rossini, C.; Fuselli, S.R. Chemical Composition, Antimicrobial Activity, and Mode of Action of Essential Oils against Paenibacillus larvae, Etiological Agent of American Foulbrood on Apis mellifera. Chem. Biodivers. 2017, 14, e1600382. [Google Scholar] [CrossRef]
  127. Reyes, M.G.; Torres, M.J.; Maggi, M.D.; Marioli, J.M.; Gil, R.R.; Sosa, V.E.; Uriburu, M.L.; Audisio, M.C. In vitro inhibition of Paenibacillus larvae by different extracts and pure compounds from Flourensia spp. Ind. Crops Prod. 2013, 50, 758–763. [Google Scholar] [CrossRef]
  128. Hernández-López, J.; Crockett, S.; Kunert, O.; Hammer, E.; Schuehly, W.; Bauer, R.; Crailsheim, K.; Riessberger-Gallé, U. In vitro growth inhibition by Hypericum extracts and isolated pure compounds of Paenibacillus larvae, a lethal disease affecting honeybees worldwide. Chem. Biodivers. 2014, 11, 695–708. [Google Scholar] [CrossRef] [PubMed]
  129. Anjum, S.I.; Ayaz, S.; Shah, A.H.; Khan, S.; Khan, S.N. Controlling honeybee pathogen by using neem and Barbaka plant extracts. Biotechnol. Biotechnol. Equip. 2015, 29, 901–906. [Google Scholar] [CrossRef]
  130. González, M.J.; Marioli, J.M. Antibacterial activity of water extracts and essential oils of various aromatic plants against Paenibacillus larvae, the causative agent of American Foulbrood. J. Invertebr. Pathol. 2010, 104, 209–213. [Google Scholar] [CrossRef]
  131. Sabate, D.C.; Gonzalez, M.J.; Porrini, M.P.; Eguaras, M.J.; Audisio, M.C.; Marioli, J.M. Synergistic effect of surfactin from Bacillus subtilis C4 and Achyrocline satureioides extracts on the viability of Paenibacillus larvae. World J. Microbiol. Biotechnol. 2012, 28, 1415–1422. [Google Scholar] [CrossRef]
  132. González, M.J.; Beoletto, V.G.; Agnese, A.M.; Audisio, M.C.; Marioli, J.M. Purification of substances from Achyrocline satureioides with inhibitory activity against Paenibacillus larvae, the causal agent of American foulbrood in honeybees’ larvae. Appl. Biochem. Biotechnol. 2015, 175, 3349–3359. [Google Scholar] [CrossRef]
  133. Gende, L.B.; Principal, J.; Maggi, M.D.; Palacios, S.M.; Fritz, R.; Eguaras, M.J. Extracto de Melia azedarach y aceites esenciales de Cinnamomun zeylanicum, Mentha piperita y Lavandula officinalis como controlde Paenibacillus larvae. Zootec. Trop. 2008, 26, 151–156. [Google Scholar]
  134. Boligon, A.A.; de Brum, T.F.; Zadra, M.; Piana, M.; dos Santos Alves, C.F.; Fausto, V.P.; dos Santos Barboza, V., Jr.; de Almeida Vaucher, R.; Santos, R.C.V.; Athayde, M.L. Antimicrobial activity of Scutia buxifolia against the honeybee pathogen Paenibacillus larvae. J. Invertebr. Pathol. 2013, 112, 105–107. [Google Scholar] [CrossRef]
  135. Piana, M.; de Brum, T.F.; Boligon, A.A.; Alves, C.F.S.; de Freitas, R.B.; Nunes, L.T.; Mossmann, N.J.; Janovik, V.; Jesus, R.S.; Vaucher, R.A. In vitro growth-inhibitory effect of Brazilian plants extracts against Paenibacillus larvae and toxicity in bees. An. Acad. Bras. Cienc. 2015, 87, 1041–1047. [Google Scholar] [CrossRef]
  136. Kim, J.; Park, S.; Shin, Y.-K.; Kang, H.; Kim, K.-Y. In vitro antibacterial activity of macelignan and corosolic acid against the bacterial bee pathogens Paenibacillus larvae and Melissococcus plutonius. Acta Vet. Brno 2018, 87, 277–284. [Google Scholar] [CrossRef]
  137. Hassona, N.M.K. Using natural products to control foulbrood diseases in honey bee Apis mellifera L. colonies under egyptian conditions. Menoufia J. Plant Prot. 2017, 2, 153–165. [Google Scholar] [CrossRef]
  138. Kevan, S.D.; Nasr, M.E.; Kevan, P.G. Natural oils and other substances for mite control in honey bees. Hivelights 1999, 12, 15–16. [Google Scholar]
  139. Albo, G.N.; Henning, C.; Ringuelet, J.; Reynaldi, F.J.; De Giusti, M.R.; Alippi, A.M. Evaluation of some essential oils for the control and prevention of American Foulbrood disease in honey bees. Apidologie 2003, 34, 417–427. [Google Scholar] [CrossRef]
  140. Fries, I. Nosema ceranae in European honey bees (Apis mellifera). J. Invertebr. Pathol. 2010, 103, S73–S79. [Google Scholar] [CrossRef] [PubMed]
  141. Wang, J.-Y. Interactions Microsporidies-Insectes In Vivo: Dissémination de Nosema bombycis (Microsporidia) dans son Hôte Bombyx mori (Lepidoptera) et Caractérisation de Protéines Structurales Majeures de N. bombycis Impliquées dans L’invasion. Doctoral Dissertation, Université Blaise Pascal-Clermont-Ferrand II, Université d’Auvergne-Clermont-Ferrand I, Clermont-Ferrand, France, 2007. [Google Scholar]
  142. Maistrello, L.; Lodesani, M.; Costa, C.; Leonardi, F.; Marani, G.; Caldon, M.; Mutinelli, F.; Granato, A. Screening of natural compounds for the control of nosema disease in honeybees (Apis mellifera). Apidologie 2008, 39, 436–445. [Google Scholar] [CrossRef]
  143. Glavinic, U.; Blagojevic, J.; Ristanic, M.; Stevanovic, J.; Lakic, N.; Mirilovic, M.; Stanimirovic, Z. Use of thymol in Nosema ceranae control and health improvement of infected honey bees. Insects 2022, 13, 574. [Google Scholar] [CrossRef]
  144. Bravo, J.; Carbonell, V.; Sepúlveda, B.; Delporte, C.; Valdovinos, C.E.; Martín-Hernández, R.; Higes, M. Antifungal activity of the essential oil obtained from Cryptocarya alba against infection in honey bees by Nosema ceranae. J. Invertebr. Pathol. 2017, 149, 141–147. [Google Scholar] [CrossRef]
  145. Mitrea, I.L. In vitro” studies on using natural essential oils in treatment of Nosemosis in honey bees: Determination of the therapeutic dose. Sci. Work. Ser. C Vet. Med. 2017, 63, 165–170. [Google Scholar]
  146. Kim, J.H.; Park, J.K.; Lee, J.K. Evaluation of Antimicrosporidian Activity of Plant Extracts on. J. Apic. Sci. 2016, 60, 167–178. [Google Scholar]
  147. Lee, J.K.; Kim, J.H.; Mina, J.; Rangachari, B.; Park, J.K. Anti-nosemosis activity of Aster scaber and Artemisia dubia aqueous extracts. J. Apic. Sci. 2018, 62, 27. [Google Scholar] [CrossRef]
  148. Ptaszyńska, A.A.; Załuski, D. Extracts from Eleutherococcus senticosus (Rupr. et Maxim.) Maxim. roots: A new hope against honeybee death caused by nosemosis. Molecules 2020, 25, 4452. [Google Scholar] [CrossRef]
  149. Kunat, M.; Wagner, G.K.; Staniec, B.; Jaszek, M.; Matuszewska, A.; Stefaniuk, D.; Ptaszyńska, A.A. Aqueous extracts of jet-black ant Lasius fuliginosus nests for controlling nosemosis, a disease of honeybees caused by fungi of the genus Nosema. Eur. Zool. J. 2020, 87, 770–780. [Google Scholar] [CrossRef]
  150. Glavinic, U.; Stevanovic, J.; Ristanic, M.; Rajkovic, M.; Davitkov, D.; Lakic, N.; Stanimirovic, Z. Potential of fumagillin and Agaricus blazei mushroom extract to reduce Nosema ceranae in honey bees. Insects 2021, 12, 282. [Google Scholar] [CrossRef] [PubMed]
  151. Glavinic, U.; Rajkovic, M.; Vunduk, J.; Vejnovic, B.; Stevanovic, J.; Milenkovic, I.; Stanimirovic, Z. Effects of Agaricus bisporus mushroom extract on honey bees infected with Nosema ceranae. Insects 2021, 12, 915. [Google Scholar] [CrossRef] [PubMed]
  152. Nanetti, A.; Ugolini, L.; Cilia, G.; Pagnotta, E.; Malaguti, L.; Cardaio, I.; Matteo, R.; Lazzeri, L. Seed meals from Brassica nigra and Eruca sativa control artificial Nosema ceranae infections in Apis mellifera. Microorganisms 2021, 9, 949. [Google Scholar] [CrossRef] [PubMed]
  153. Arismendi, N.; Vargas, M.; López, M.D.; Barría, Y.; Zapata, N. Promising antimicrobial activity against the honey bee parasite Nosema ceranae by methanolic extracts from Chilean native plants and propolis. J. Apic. Res. 2018, 57, 522–535. [Google Scholar] [CrossRef]
  154. Mura, A.; Pusceddu, M.; Theodorou, P.; Angioni, A.; Floris, I.; Paxton, R.J.; Satta, A. Propolis consumption reduces Nosema ceranae infection of European honey bees (Apis mellifera). Insects 2020, 11, 124. [Google Scholar] [CrossRef]
  155. Suwannapong, G.; Maksong, S.; Phainchajoen, M.; Benbow, M.E.; Mayack, C. Survival and health improvement of Nosema infected Apis florea (Hymenoptera: Apidae) bees after treatment with propolis extract. J. Asia. Pac. Entomol. 2018, 21, 437–444. [Google Scholar] [CrossRef]
  156. Naree, S.; Ellis, J.D.; Benbow, M.E.; Suwannapong, G. The use of propolis for preventing and treating Nosema ceranae infection in western honey bee (Apis mellifera Linnaeus, 1787) workers. J. Apic. Res. 2021, 60, 686–696. [Google Scholar] [CrossRef]
  157. Cilia, G.; Garrido, C.; Bonetto, M.; Tesoriero, D.; Nanetti, A. Effect of Api-Bioxal® and ApiHerb® treatments against Nosema ceranae infection in Apis mellifera investigated by two qPCR methods. Vet. Sci. 2020, 7, 125. [Google Scholar] [CrossRef]
  158. Wood, M. Microbes help bees battle chalkbrood. Agric. Res. 1998, 46, 16. [Google Scholar]
  159. Starks, P.T.; Blackie, C.A.; Seeley, T.D. Fever in honeybee colonies. Naturwissenschaften 2000, 87, 229–231. [Google Scholar] [CrossRef] [PubMed]
  160. Gochnauer, T.A.; Boch, R.; Margetts, V.J. Inhibition of Ascosphaera apis by citral and geraniol. J. Invertebr. Pathol. 1979, 34, 57–61. [Google Scholar] [CrossRef]
  161. Calderone, N.W.; Shimanuki, H.; Allen-Wardell, G. An in vitro evaluation of botanical compounds for the control of the honeybee pathogens Bacillus larvae and Ascosphaera apis, and the secondary invader B. alvei. J. Essent. Oil Res. 1994, 6, 279–287. [Google Scholar] [CrossRef]
  162. Dellacasa, A.D.; Bailac, P.N.; Ponzi, M.I.; Ruffinengo, S.R.; Eguaras, M.J. In vitro activity of essential oils from San Luis-Argentina against Ascosphaera apis. J. Essent. Oil Res. 2003, 15, 282–285. [Google Scholar] [CrossRef]
  163. Davis, G.; Ward, W. Control of Chalkbrood Disease with Natural Products; RIRDC: Wagga Wagga, Australia, 2003. [Google Scholar]
  164. Ruffinengo, S.R.; Maggi, M.; Fuselli, S.; Floris, I.; Clemente, G.; Firpo, N.H.; Bailac, P.N.; Ponzi, M.I. Laboratory evaluation of Heterothalamus alienus essential oil against different pests of Apis mellifera. J. Essent. Oil Res. 2006, 18, 704–707. [Google Scholar] [CrossRef]
  165. El-enain, A.; Aldel-Rahman, M.F.; Abo-Elyousr, K.A.M. Inhibitory activity of certain natural products on the growth of Ascosphaera apıs. Ass. Univ. Bull. Environ. Res 2009, 12, 99–106. [Google Scholar]
  166. Gabriel, K.T.; Kartforosh, L.; Crow, S.A.; Cornelison, C.T. Antimicrobial activity of essential oils against the fungal pathogens Ascosphaera apis and Pseudogymnoascus destructans. Mycopathologia 2018, 183, 921–934. [Google Scholar] [CrossRef]
  167. Ansari, M.J.; Al-Ghamdi, A.; Usmani, S.; Khan, K.A.; Alqarni, A.S.; Kaur, M.; Al-Waili, N. In vitro evaluation of the effects of some plant essential oils on Ascosphaera apis, the causative agent of Chalkbrood disease. Saudi J. Biol. Sci. 2017, 24, 1001–1006. [Google Scholar] [CrossRef]
  168. Kloucek, P.; Smid, J.; Flesar, J.; Havlik, J.; Titera, D.; Rada, V.; Drabek, O.; Kokoska, L. In vitro inhibitory activity of essential oil vapors against Ascosphaera apis. Nat. Prod. Commun. 2012, 7, 1934578X1200700237. [Google Scholar] [CrossRef]
  169. Pusceddu, M.; Floris, I.; Mangia, N.P.; Angioni, A.; Satta, A. In vitro activity of several essential oils extracted from aromatic plants against Ascosphaera apis. Vet. Sci. 2021, 8, 80. [Google Scholar] [CrossRef] [PubMed]
  170. Nazzi, F.; Brown, S.P.; Annoscia, D.; Del Piccolo, F.; Di Prisco, G.; Varricchio, P.; Vedova, G.D.; Cattonaro, F.; Caprio, E.; Pennacchio, F. Synergistic parasite-pathogen interactions mediated by host immunity can drive the collapse of honeybee colonies. PLoS Pathog. 2012, 8, e1002735. [Google Scholar] [CrossRef] [PubMed]
  171. Li, Z.; Chen, Y.; Zhang, S.; Chen, S.; Li, W.; Yan, L.; Shi, L.; Wu, L.; Sohr, A.; Su, S. Viral infection affects sucrose responsiveness and homing ability of forager honey bees, Apis mellifera L. PLoS ONE 2013, 8, e77354. [Google Scholar] [CrossRef]
  172. Boncristiani, H.F.; Evans, J.D.; Chen, Y.; Pettis, J.; Murphy, C.; Lopez, D.L.; Simone-Finstrom, M.; Strand, M.; Tarpy, D.R.; Rueppell, O. In vitro infection of pupae with Israeli acute paralysis virus suggests disturbance of transcriptional homeostasis in honey bees (Apis mellifera). PLoS ONE 2013, 8, e73429. [Google Scholar] [CrossRef] [PubMed]
  173. Chen, Y.P.; Pettis, J.S.; Corona, M.; Chen, W.P.; Li, C.J.; Spivak, M.; Visscher, P.K.; DeGrandi-Hoffman, G.; Boncristiani, H.; Zhao, Y. Israeli acute paralysis virus: Epidemiology, pathogenesis and implications for honey bee health. PLoS Pathog. 2014, 10, e1004261. [Google Scholar] [CrossRef]
  174. Chen, Y.; Zhao, Y.; Hammond, J.; Hsu, H.; Evans, J.; Feldlaufer, M. Multiple virus infections in the honey bee and genome divergence of honey bee viruses. J. Invertebr. Pathol. 2004, 87, 84–93. [Google Scholar] [CrossRef]
  175. Aurori, A.C.; Bobiş, O.; Dezmirean, D.S.; Mărghitaş, L.A.; Erler, S. Bay laurel (Laurus nobilis) as potential antiviral treatment in naturally BQCV infected honeybees. Virus Res. 2016, 222, 29–33. [Google Scholar] [CrossRef]
  176. Boncristiani, D.L.; Tauber, J.P.; Palmer-Young, E.C.; Cao, L.; Collins, W.; Grubbs, K.; Lopez, J.A.; Meinhardt, L.W.; Nguyen, V.; Oh, S. Impacts of diverse natural products on honey bee viral loads and health. Appl. Sci. 2021, 11, 10732. [Google Scholar] [CrossRef]
  177. Kamei, M.; Nishimura, H.; Takahashi, T.; Takahashi, N.; Inokuchi, K.; Mato, T.; Takahashi, K. Anti-influenza virus effects of cocoa. J. Sci. Food Agric. 2016, 96, 1150–1158. [Google Scholar] [CrossRef]
  178. de la Luz Cádiz-Gurrea, M.; Fernández de las Nieves, I.; Aguilera Saez, L.M.; Fernández-Arroyo, S.; Legeai-Mallet, L.; Bouaziz, M.; Segura-Carretero, A. Bioactive compounds from Theobroma cacao: Effect of isolation and safety evaluation. Plant Foods Hum. Nutr. 2019, 74, 40–46. [Google Scholar] [CrossRef]
  179. Dang, Y.K.T.; Nguyen, H.V.H. Effects of maturity at harvest and fermentation conditions on bioactive compounds of cocoa beans. Plant Foods Hum. Nutr. 2019, 74, 54–60. [Google Scholar] [CrossRef] [PubMed]
  180. Hu, S.; Kim, B.-Y.; Baik, M.-Y. Physicochemical properties and antioxidant capacity of raw, roasted and puffed cacao beans. Food Chem. 2016, 194, 1089–1094. [Google Scholar] [CrossRef] [PubMed]
  181. Salvador, I.; Massarioli, A.P.; Silva, A.P.S.; Malaguetta, H.; Melo, P.S.; Alencar, S.M. Can we conserve trans-resveratrol content and antioxidant activity during industrial production of chocolate? J. Sci. Food Agric. 2019, 99, 83–89. [Google Scholar] [CrossRef] [PubMed]
  182. Haghmorad, D.; Mahmoudi, M.B.; Salehipour, Z.; Jalayer, Z.; Rastin, M.; Kokhaei, P.; Mahmoudi, M. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis. J. Neuroimmunol. 2017, 302, 23–33. [Google Scholar] [CrossRef] [PubMed]
  183. Traynor, K.S.; Mondet, F.; de Miranda, J.R.; Techer, M.; Kowallik, V.; Oddie, M.A.Y.; Chantawannakul, P.; McAfee, A. Varroa destructor: A complex parasite, crippling honey bees worldwide. Trends Parasitol. 2020, 36, 592–606. [Google Scholar] [CrossRef]
  184. Ramsey, S.D.; Ochoa, R.; Bauchan, G.; Gulbronson, C.; Mowery, J.D.; Cohen, A.; Lim, D.; Joklik, J.; Cicero, J.M.; Ellis, J.D. Varroa destructor feeds primarily on honey bee fat body tissue and not hemolymph. Proc. Natl. Acad. Sci. USA 2019, 116, 1792–1801. [Google Scholar] [CrossRef]
  185. Boecking, O.; Genersch, E. Varroosis—The ongoing crisis in bee keeping. J. Fur Verbraucherschutz Und Leb. 2008, 3, 221–228. [Google Scholar] [CrossRef]
  186. Rinkevich, F.D. Detection of amitraz resistance and reduced treatment efficacy in the Varroa Mite, Varroa destructor, within commercial beekeeping operations. PLoS ONE 2020, 15, e0227264. [Google Scholar] [CrossRef]
  187. Sara Hernández-Rodríguez, C.; Marín, Ó.; Calatayud, F.; Mahiques, M.J.; Mompó, A.; Segura, I.; Simó, E.; González-Cabrera, J. Large-Scale Monitoring of Resistance to Coumaphos, Amitraz, and Pyrethroids in Varroa destructor. Insects 2021, 12, 27. [Google Scholar] [CrossRef]
  188. Bogdanov, S.; Liebefeld, A. Contaminants of bee products. Apidologie 2006, 37, 1–18. [Google Scholar] [CrossRef]
  189. Lin, Z.; Su, X.; Wang, S.; Ji, T.; Hu, F.L.; Zheng, H.Q. Fumigant toxicity of eleven Chinese herbal essential oils against an ectoparasitic mite (Varroa destructor) of the honey bee (Apis mellifera). J. Apic. Res. 2020, 59, 204–210. [Google Scholar] [CrossRef]
  190. Umpiérrez, M.L.; Santos, E.; Mendoza, Y.; Altesor, P.; Rossini, C. Essential oil from Eupatorium buniifolium leaves as potential varroacide. Parasitol. Res. 2013, 112, 3389–3400. [Google Scholar] [CrossRef] [PubMed]
  191. Ruffinengo, S.R.; Eguaras, M.J.; Cora, D.; Rodriguez, E.; Bedascarrasbure, E.; Bailac, P.N.; Ponzi, M.I. Biological activity of Heterotheca latifolia essential oil against Varroa jacobsoni. J. Essent. Oil Res. 2002, 14, 462–464. [Google Scholar] [CrossRef]
  192. Conti, B.; Bocchino, R.; Cosci, F.; Ascrizzi, R.; Flamini, G.; Bedini, S. Essential oils against Varroa destructor: A soft way to fight the parasitic mite of Apis mellifera. J. Apic. Res. 2020, 59, 774–782. [Google Scholar] [CrossRef]
  193. Bava, R.; Castagna, F.; Palma, E.; Marrelli, M.; Conforti, F.; Musolino, V.; Carresi, C.; Lupia, C.; Ceniti, C.; Tilocca, B. Essential Oils for a Sustainable Control of Honeybee Varroosis. Vet. Sci. 2023, 10, 308. [Google Scholar] [CrossRef] [PubMed]
  194. Romo-Chacón, A.; Martínez-Contreras, L.J.; Molina-Corral, F.J.; Acosta-Muñiz, C.H.; Ríos-Velasco, C.; De León-Door, A.P.; Rivera, R. Evaluation of Oregano (Lippia berlandieri) Essential Oil and Entomopathogenic Fungi for Varroa destructor Control in Colonies of Honey Bee, Apis mellifera. Southwest. Entomol. 2016, 41, 971–982. [Google Scholar] [CrossRef]
  195. Sinia, A.; Guzman-Novoa, E. Evaluation of the entomopathogenic fungi Beauveria bassiana GHA and Metarhizium anisopliae UAMH 9198 alone or in combination with thymol for the control of Varroa destructor in honey bee (Apis mellifera ) colonies. J. Apic. Res. 2018, 57, 308–316. [Google Scholar] [CrossRef]
  196. Sammataro, D.; Degrandi-Hoffman, G.; Needham, G.; Wardell, G. Some Volatile Plant Oils as Potential Control Agents for Varroa Mites (Acari: Varroidae) in Honey Bee Colonies (Hymenoptera: Apidae). Am. Bee J. 1998, 138, 681–685. [Google Scholar]
  197. da Costa Vieira, G.H.; da Paz Andrade, W.; do Nascimento, D.M. Use of essential oils for controlling the Varroa destructor acarus in Apis mellifera. Pesqui. Agropecuária Trop. 2012, 42, 317–322. [Google Scholar] [CrossRef]
  198. Su, X.; Zheng, H.; Fei, Z.; Hu, F. Effectiveness of herbal essential oils as fumigants to control Varroa destructor in laboratory assays. Chin. J. Appl. Entomol. 2012, 49, 1189–1195. [Google Scholar]
  199. Ghasemi, V.; Moharramipour, S.; Tahmasbi, G.H. Laboratory cage studies on the efficacy of some medicinal plant essential oils for controlling varroosis in Apis mellifera (Hym.: Apidae). Syst. Appl. Acarol. 2016, 21, 1681–1692. [Google Scholar] [CrossRef]
  200. Aglagane, A.; Laghzaoui, E.-M.; Soulaimani, B.; Er-Rguibi, O.; Abbad, A.; El Mouden, E.H.; Aourir, M. Acaricidal activity of Mentha suaveolens subsp. timija, Chenopodium ambrosioides, and Laurus nobilis essential oils, and their synergistic combinations against the ectoparasitic bee mite, Varroa destructor (Acari: Varroidae). J. Apic. Res. 2022, 61, 9–18. [Google Scholar] [CrossRef]
  201. Fuselli, S.R.; Maggi, M.; García De La Rosa, S.B.; Principal, J.; Eguaras, M.J.; Fritz, R. In vitro antibacterial and antiparasitic effect of citrus fruit essential oils on the honey bee pathogen Paenibacillus larvae and the parasitic mite Varroa destructor. J. Apic. Res. 2009, 48, 77–78. [Google Scholar] [CrossRef]
  202. Sergio, R.R.; Maggi, M.D.; Fuselli, S.; Fiorella, G.; Negri, P.; Brasesco, C.; Satta, A.; Floris, I.; Eguaras, M.J. Bioactivity of microencapsulated essentials oils and perspectives of their use in the control of Varroa destructor. Bull. Insectology 2014, 67, 81–86. [Google Scholar]
  203. Hýbl, M.; Bohatá, A.; Rádsetoulalová, I.; Kopecký, M.; Hoštičková, I.; Vaníčková, A.; Mráz, P. Evaluating the Efficacy of 30 Different Essential Oils against Varroa destructor and Honey Bee Workers (Apis mellifera). Insects 2021, 12, 1045. [Google Scholar] [CrossRef]
  204. Gashout, H.A.; Guzmán-Novoa, E. Acute toxicity of Essential oils and other natural compounds to the parasitic mite, Varroa destructor, and to larval and adult worker honey bees (Apis mellifera L.). J. Apic. Res. 2009, 48, 263–269. [Google Scholar] [CrossRef]
Figure 1. Major pathogens that affect honeybees. The primary pathogens that infect Apis mellifera are shown schematically as members of the taxonomic grouping of fungi, bacteria, and viruses. An area of the image has been entirely dedicated to V. destructor for its important role as a vector of pathogens.
Figure 1. Major pathogens that affect honeybees. The primary pathogens that infect Apis mellifera are shown schematically as members of the taxonomic grouping of fungi, bacteria, and viruses. An area of the image has been entirely dedicated to V. destructor for its important role as a vector of pathogens.
Pathogens 12 01260 g001
Table 1. Botanical species used for pathogens control in honeybee and their targets.
Table 1. Botanical species used for pathogens control in honeybee and their targets.
Botanical NameCommon NameActivityReferences
Acantholippia seriphioidesAcantholippiaV. destructor
Paenibacillus larvae
[36,126,202]
Achyrocline satureioidesMacelaPaenibacillus larvae[130,131,132]
Allium sativumGarlicAscosphaera apis[168]
Aloysia gratissimaBeebrush, WhitebrushPaenibacillus larvae[162]
Aloysia polystachyaBeebrushPaenibacillus larvae[126]
Aristotelia chilensisChilean wineberryNosema spp.[153]
Armoracia rusticanaHorseradishPaenibacillus larvae
Ascosphaera apis
[122,168]
Artemisia dubiaMugwortNosema spp.[146]
Aster scaberChwinamulNosema spp.[146]
Azadirachta indicaNeemPaenibacillus larvae[129]
Baccharis coridifoliaMio-mio, VassourinhaAscosphaera apis[162]
Baccharis latifoliaChilcaPaenibacillus larvae[126]
Brassica nigraBlack mustardNosema spp.[152]
Buddleja globosaOrange-ball-tree, orange ballPaenibacillus larvae[126]
Calendula officinalisPot marigoldPaenibacillus larvae[135]
Camellia sinensisTea plant, tea bushNosema spp.[148]
Chenopodium ambrosioidesMexican teaPaenibacillus larvae[130]
Cinnamomum sp.CinnamonAscosphaera apis[166]
Cinnamomum zeylanicumDalchiniMelissococcus plutonius
Paenibacillus larvae Ascosphaera apis
[7,137,169]
Citrus reticulataMandarin orangeAscosphaera apis[165]
Citrus spp. (hesperidin)CitrusV. destructor
Deformed wing virus (DWV)
[8,176]
Coriander sativumCilantro, Chinese parsleyNosema spp.[145]
Cryptocaria albaPeumoNosema spp.[144]
Cymbopogon citratusLemongrassPaenibacillus larva; Ascosphaera apis[35]
Cymbopogon flexosusLemongrassAscosphaera apis[168]
Eleutherococcus senticosusSiberian ginseng, eleutheroNosema spp.[148]
Eruca sativaRocket leavesNosema spp.[152]
Eucalyptus cinereaArgyle applePaenibacillus larvae[130]
Eucalyptus citriodoraLemon-scented gumAscosphaera apis[163]
Eucalyptus globulusTasmanian bluegumPaenibacillus larvae[35]
Eupatorium patensBonesetAscosphaera apis[162]
Flourensia fiebrigiiChilca, maravillaPaenibacillus larvae[127]
Flourensia ripariaRiparian FlourensiaPaenibacillus larvae[127]
Flourensia tortuosaFlourensiaPaenibacillus larvae[127]
Foeniculum spp.FennelV. destructor[37]
Foeniculum vulgareFennelAscosphaera apis[165]
Garcinia cambogiaGambooge, Malabar TamarindNosema spp.[148]
Gevuina avellanaChilean wildnutNosema spp.[153]
Gnaphalium gaudichaudianumPseudognaphaliumPaenibacillus larvae[130]
Heterothalamus alienusRomerilloAscosphaera apis[164]
Heterotheca latifoliaCamphorweedAscosphaera apis[162]
Hypericum spp.Common St. John’s wortPaenibacillus larvae[128]
Laurus nobilisBay laurelV. destructor
Paenibacillus larvae
Black queen cell virus (BQCV)
[117,175,196]
Lavandula hybridaLavandinPaenibacillus larvae[35]
Leptospermum petersoniiLemon-scented tea-treeAscosphaera apis[163]
Leptospermum scopariumTea-treeAscosphaera apis[163]
Lippia integrifoliaHieronAscosphaera apis[162]
Lippia junelianaLippia juneliaAscosphaera apis[162]
Lippia turbinataLippia turbinataPaenibacillus larvae; Ascosphaera apis[126,130,162]
Litsea cubebaMountain pepperAscosphaera apis[7]
Marrubium vulgareWhite horehoundPaenibacillus larvae[130]
Melia azedarachChinaberry treePaenibacillus larvae[133]
Melissa officinalisLemon balmNosema spp.[145]
Mentha piperitaPeppermintPaenibacillus larvae
Nosema spp.
[35,145]
Mentha spicata var. crispaPeppermintPaenibacillus larvae[122]
Minthostachys mollisMuña, PeperinaPaenibacillus larvae[126]
Minthostachys verticillataPeperinaPaenibacillus larvae[130]
Nasturtium officinaleWatercressPaenibacillus larvae[135]
Origanum spp.OreganoV. destructor[12,204]
Origanum vulgareOreganoPaenibacillus larvae
Ascosphaera apis
[35,125,130,168]
Pelargonium graveolensRose geraniumAscosphaera apis[7]
Pimenta racemosaBay rum treeAscosphaera apis[161]
Polygonum bistortaMeadow bistortMelissococcus plutonius
Paenibacillus larvae
[124]
Salvia RosmarinusRosemaryPaenibacillus larvae[35]
Satureja hortensisCibru, savoryPaenibacillus larvae
Nosema spp.
[35,122,145]
Schinus mollePeruvian peppertreePaenibacillus larvae
Nosema spp.
[126]
Schisandra chinensisChinese magnolia vineNosema spp.[148]
Scutia buxifoliaBoxleaf scutiaPaenibacillus larvae[134]
Solidago chilensisGoldenrodPaenibacillus larvae[126]
Syzygium aromaticumCloveV. destructor
Paenibacillus larvae
Ascosphaera apis
Melissococcus plutonius
[125,137,161,196,197]
Tagetes minutaStinking RogerPaenibacillus larvae[130]
Tessaria absinthioidesTessariaAscosphaera apis[162]
Theobroma cacaoCocoa, cacaoDeformed wing virus (DWV)[176]
Thymus capitatusConehead thymeAscosphaera apis[161,169]
Thymus herba-baronaCaraway thymeAscosphaera apis[169]
Thymus vulgarisGerman thymeMelissococcus plutonius
Paenibacillus larvae
Ascosphaera apis
[35,122,125,130,137,168]
Ugni molinaeChilean guava, strawberry myrtleNosema spp.[153]
Chrysopogon zizanioidesVetiverNosema spp.[142]
Vitex trifoliaSimpleleaf chastetreePaenibacillus larvae[129]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bava, R.; Castagna, F.; Ruga, S.; Nucera, S.; Caminiti, R.; Serra, M.; Bulotta, R.M.; Lupia, C.; Marrelli, M.; Conforti, F.; et al. Plants and Their Derivatives as Promising Therapeutics for Sustainable Control of Honeybee (Apis mellifera) Pathogens. Pathogens 2023, 12, 1260. https://doi.org/10.3390/pathogens12101260

AMA Style

Bava R, Castagna F, Ruga S, Nucera S, Caminiti R, Serra M, Bulotta RM, Lupia C, Marrelli M, Conforti F, et al. Plants and Their Derivatives as Promising Therapeutics for Sustainable Control of Honeybee (Apis mellifera) Pathogens. Pathogens. 2023; 12(10):1260. https://doi.org/10.3390/pathogens12101260

Chicago/Turabian Style

Bava, Roberto, Fabio Castagna, Stefano Ruga, Saverio Nucera, Rosamaria Caminiti, Maria Serra, Rosa Maria Bulotta, Carmine Lupia, Mariangela Marrelli, Filomena Conforti, and et al. 2023. "Plants and Their Derivatives as Promising Therapeutics for Sustainable Control of Honeybee (Apis mellifera) Pathogens" Pathogens 12, no. 10: 1260. https://doi.org/10.3390/pathogens12101260

APA Style

Bava, R., Castagna, F., Ruga, S., Nucera, S., Caminiti, R., Serra, M., Bulotta, R. M., Lupia, C., Marrelli, M., Conforti, F., Statti, G., Domenico, B., & Palma, E. (2023). Plants and Their Derivatives as Promising Therapeutics for Sustainable Control of Honeybee (Apis mellifera) Pathogens. Pathogens, 12(10), 1260. https://doi.org/10.3390/pathogens12101260

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop